A computational study of post-infarct mechanical effects of injected biomaterial into ischaemic myocardium by Miller, Renee
  
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
 
 
 
 
 
A Computational Study of Post-Infarct Mechanical Effects 
of Injected Biomaterial into Ischaemic Myocardium 
 
 
Department of Human Biology 
Biomedical Engineering 
 
presented for the degree of 
MSc (Med) in Biomedical Engineering 
 
 
Author: Renee Miller (Student No: MLLREN003) 
Supervisor: Assoc. Prof. Thomas Franz 
Co-Supervisor: Dr. Neil Davies 
 
Cardiovascular Research Unit, University of Cape Town 
 
September 2012 
 
 
 
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
ii 
 
DECLARATION 
I, Renee Miller, hereby declare that the work on which this dissertation is based is my 
original work (except where acknowledgements indicate otherwise) and that neither 
the whole work nor any part of it has been, is being, or is to be submitted for another 
degree in this or any other university. I empower the university to reproduce for the 
purpose of research either the whole or any portion of the contents in any manner 
whatsoever. 
 
Signature: ………………………………… 
 
Date: September 28, 2012 
 
 
 
 
 
 
 
 
 
 
 
 
  
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
iii 
 
Abstract 
Cardiovascular diseases account for one third of all deaths worldwide, more than 33% 
of which are related to ischaemic heart disease, involving a myocardial infarction (MI). 
Emerging MI therapies involving biomaterial injections have shown some benefits; the 
underlying mechanisms of which remain unclear. Computational models offer 
considerable potential to study the biomechanics of a myocardial infarction and novel 
therapies. 
Geometrical data of a healthy human left ventricle (LV) obtained from magnetic 
resonance images (MRI) was used to create a finite element (FE) mesh of the LV at the 
end-systolic time point using Continuity® 6.3 (University of California in San Diego, 
US). A mesh of 96 hexahedral elements with high order basis functions was employed 
to adequately describe the geometry of the LV. Simulations of diastolic filling and 
systolic contraction were performed using a transversely isotropic exponential strain 
energy function and a model for active stress based on contraction at the cellular level. 
An anterior apical, transmural MI was modelled in the LV encompassing 16% of the LV 
wall volume. The infarct was modelled at acute and fibrotic stages of post-infarct LV 
remodelling by altering the constitutive and active stress models to best describe 
passive and active behaviour of the ischaemic myocardium at each time point. The 
geometry of the LV with the fibrotic infarct was adjusted to represent the wall thinning 
that occurs during LV post-MI remodelling. Hydrogel injection was modelled as layers 
with material properties differing from those of the surrounding myocardium while 
accounting for thickening of the LV wall at the injection site. The study design 
comprised a healthy case and two infarcted cases with and without hydrogel injection. 
The end-diastolic volume (EDV) increased in the acute infarct model compared to the 
healthy case due to the reduced stiffness in the infarct wall. An EDV increase was not 
observed in the fibrotic infarct model compared to the healthy case. This was partially 
attributed to the increase in infarct stiffness and partially due to the fact that 
remodelling-related dilation of the LV was not implemented in the model. Inclusion of 
hydrogel lowered EDV in both the acute and fibrotic models. The predicted ejection 
fraction (EF) decreased from 41.2% for the healthy case to 28.5% and 33.0% for the 
acute and fibrotic infarct models, respectively. Inclusion of hydrogel layers caused an 
improvement in EF in the acute model only.  
Elevated myofibre stress in the remote and border zone (BZ) regions in a post-MI LV 
undergoing remodelling leads to hypertrophy and eventual heart failure. Therefore, 
myofibre stresses were compared at both end-diastolic (ED) and end-systolic (ES) 
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
iv 
 
points in the cardiac cycle. The acute infarct, less stiff than healthy myocardium, 
resulted in lower myofibre stresses in the infarct region at both end-diastole and end-
systole. However, remote and BZ myofibre stresses increased. The stiff fibrotic infarct, 
with a thinned wall, exhibited higher myofibre stresses in the infarct, remote and BZ 
regions than in the healthy case. Simulated injection of hydrogel reduced overall LV ED 
myofibre stresses in both the acute and fibrotic infarct cases. At end-systole, the acute 
and fibrotic infarcts caused an increase in myofibre stress in the BZ and entire LV. 
Addition of hydrogel layers reduced LV myofibre stress in the acute and fibrotic infarct 
model. Inclusion of hydrogel lowered ES myofibre stress in the BZ in both infarct 
models. Thinning of the LV wall leads to excessive distension (or bulging), limiting LV 
myocardial function. ED and ES strains from the non-treated and treated infarct models 
were compared with the healthy case to determine whether the inclusion of hydrogel 
has an impact on infarct stretching. ED strain increased from the healthy to the acute 
case in the infarct region. There was, however, negligible change in myofibre strain in 
the remote and BZ regions. The stiff fibrotic infarct caused a decrease in myofibre 
strain in the infarct region. ES myofibre strain in the healthy model was negative since 
active myocardium is contracting. However, the infarct regions in the acute and fibrotic 
models resulted in positive strain values since the ischaemic tissue can no longer 
contract. The acute infarct exhibited greater strain or distension of the infarct region 
than the fibrotic infarct. Inclusion of hydrogel lowered ED myofibre strain in each 
infarct model throughout the entire LV. Similarly, hydrogel layers considerably 
lowered ES myofibre strain, not only in the infarct region, but throughout the LV.  
Addition of the hydrogel into infarcted myocardial tissue does not have a substantial 
positive effect when only considering the cardiac functional parameters. There is no 
benefit in contractility of the LV and only a slight improvement in ejection fraction with 
hydrogel injection at the acute time point. However, the addition of hydrogel shows a 
clear improvement on myofibre stresses and strains throughout the LV. Hydrogel 
layers lower myofibre stresses in the infarct and border zone regions at both ED and ES 
time points, potentially reducing hypertrophy of remote and BZ regions. In addition, 
hydrogel layers reduce strain or distension of the infarcted and border zone tissue, 
retaining efficiency of the LV and preventing wall thinning. Therefore, hydrogel 
injection should be researched further as a possible treatment post-MI as a means of 
deterring LV remodelling and heart failure.  
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1. Introduction 
1.1. Background 
In 2004, there were 17.1 million deaths from cardiovascular diseases (CVD) 
worldwide, of which 7.2 million were attributed to coronary heart disease. 82% of CVD 
deaths take place in low- and middle-income countries, including South Africa. Lower- 
and middle-income countries are affected most due to the lack of preventive healthcare 
and solutions when catastrophic CVD related events occur (WHO, 2008). CVD is 
expected to become the leading cause of death worldwide by 2020, superseding 
infectious diseases such as HIV, TB and Malaria due to a growing epidemic of obesity, 
diabetes and uncontrolled hypertension (Lloyd-Jones et al., 2010). Currently, CVD 
account for approximately one third of all deaths in the world. More than 33% of these 
deaths are related to ischaemic heart disease, involving a myocardial infarction 
(MI)(AHA, 2008). Consequently, alternative therapies are urgently needed. 
In a healthy heart, the left ventricle (LV) expands passively during diastole as 
oxygenated blood from the lungs enters from the left atrium. During systole, the LV 
actively contracts, expelling blood through the systemic circulatory system to meet the 
body’s nutrient needs. During an MI, the blockage of a coronary artery restricts oxygen 
delivery to the cardiac tissue, causing cardiomyocyte death and loss of contractility in 
the region of the LV supplied by the blocked blood vessel. Immediately after infarction 
in non-fatal cases, in the acute phase, ischaemic tissue maintains the same passive 
properties as healthy myocardium throughout passive filling. However, systolic 
function of active ejection of blood is greatly impaired. While the healthy tissue 
continues to contract, the ischaemic tissue bulges out, increasing LV volume, absorbing 
some of the contractile mechanical energy and decreasing the efficiency of the heart. 
The enlarged LV volume causes an elevation of ventricular wall stress in an attempt to 
maintain the stroke volume to ensure adequate organ perfusion (Whelan et al., 2007). 
The healthy myocardium then contracts harder to compensate for the decreased 
mechanical output, leading to remodelling and hypertrophy of the healthy tissue in 
later phases. The increased volume and pressure load on healthy tissue can eventually 
lead to heart failure (HF) (Opie et al., 2006). Even small increases in ventricular wall 
volume post-MI, indicating hypertrophy and cardiac remodelling, point towards a poor 
prognosis and eventual HF (Konstam, 2005). Therefore, any innovative treatments or 
therapies to prevent HF must target harmful ventricular remodelling.   
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1.2. Problem Identification 
Despite advances in therapies for HF, the only definite treatment currently known is 
heart transplantation which suffers from a chronic shortage of organ donations. After 
early reperfusion, first line medical treatment usually consists of angiotensin-
converting enzyme inhibitors, angiotensin receptor blockers and beta-blockers. The 
reduction of morbidity and mortality after MI with these treatments has been credited, 
at least in part, to the attenuation and partial reversal of the remodelling of the injured 
heart (Pfeffer et al., 1992, Kober et al., 1995, Hall et al., 1995, Cohn and Tognoni, 2001, 
McMurray et al., 2003).  
With the high prevalence of HF, substantial research has been devoted towards 
developing new treatments with an emphasis on cell delivery post infarction (Fuchs et 
al., 2001, Mangi et al., 2003, Zisch et al., 2003, Kraehenbuehl et al., 2008). Results have 
demonstrated an improvement of the LV pump function. It is, however, not well 
understood whether this beneficial effect has been a result of cellular signalling, 
mechanics of the increased LV wall thickness (Grossman et al., 1975, Wall et al., 2006) 
or a combination of the two. Therefore, the potential of biomaterial delivery without 
stem cells into the ischaemic heart to tackle post-infarct remodelling have begun to be 
explored. Initial results of biomaterial injection have given reason for cautious 
optimism: Increased wall thickness (Kofidis et al., 2005, Dai et al., 2005, Landa et al., 
2008), attenuation of adverse LV remodelling (Landa et al., 2008), decreased infarct 
size (Christman et al., 2004) and improvement of functional parameters (Kofidis et al., 
2005, Dai et al., 2005, Landa et al., 2008) have all been demonstrated. It has been 
proposed that a non-degradable injectable polymer may be required for long-term 
beneficial effects on heart remodelling (Christman and Lee, 2006) while a degradable 
injectable polymer has been shown to reduce the inflammatory response caused by the 
injectate (Kadner et al., 2012). 
This recent research into biomaterial delivery for treatment of MI and prevention of HF 
has predominantly been based on pre-clinical small animal models. However, in vivo  
models are associated with challenges such as high costs of the equipment for cardiac 
physiology assessment, difficulties reproducing favourable results in clinical studies 
(Patten and Hall-Porter, 2009) and limitations in isolating causative factors. 
Computational modelling in cardiac biomechanics can provide a meaningful method 
for obtaining complementary information on mechanical mechanisms involved in a 
myocardial infarction and improve the understanding of patho-physiological processes 
involved in MI. Consequently, computational biomechanics has a considerable 
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potential to contribute to the advancement of therapies for MI and the prevention of 
heart failure. 
1.3. Aim and Objectives 
The goal of the research into myocardial infarction currently undertaken at the 
Cardiovascular Research Unit was to contribute to the understanding and 
advancement of one emerging therapy for acute MI, the injection of a polymeric 
biomaterial into the ischaemic myocardium through studying the biomechanical 
mechanisms associated with this treatment.  
Based on past in vivo studies investigating the use of injectable biomaterials as a post-
MI therapy to prevent the progression towards HF, the hypothesis for the research of 
this thesis is that a) biomaterial injectates in the infarct region lead to a reduction in 
wall stress and strain in the infarct region and the functional border zone as well as an 
increase in ventricular function compared to the infarcted case without injectate, b) 
layered injectates and bulk injectates show difference in the effects mentioned under 
(a), and c) the mechanical effects of the biomaterial injectates on ventricular mechanics 
and function differ between the ischemic and the scarred infarct stage. 
The aim of this Master’s thesis was to develop computational models, using freely 
available software, of the injection of a polymeric biomaterial into infarcted 
myocardium in a human LV and to study the effects of the injectate on myocardial 
stresses, strains and cardiac function of an infarcted LV.  
The objectives of the research were to: 
• Model an a) healthy LV, b) infarcted LV at two time points post infarction, and 
c) infarcted LV at two time points post infarction with injected biomaterial. 
• Simulate diastole and systole for each model using linear pressure/volume 
increase models. 
• Analyse resulting stresses, strains, and cardiac parameters such as ejection 
fraction and contractility to interpret the effect of injected biomaterial on the 
ischaemic heart. 
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2. Theory and Literature Review 
2.1. Anatomy and Physiology of the Heart 
2.1.1. Anatomy 
The human heart, a myogenic organ, circulates blood throughout the body through 
repeated, rhythmic contractions. It is located in the chest between the lungs and is 
encased in the pericardium, a sac that prevents friction between the heart tissue and 
surrounding organs. It is composed of the right and left atria, which receive blood from 
the body, and the right and left ventricles (RV and LV, respectively), which pump blood 
throughout the body, see Figure 2-1. The cardiac muscle is striated and involuntary, 
completely unique to this organ, and receives its blood supply through coronary 
arteries. 
 
Figure 2-1: Heart diagram outlining the major cavities, arteries, and veins of the heart 
The LV approximately resembles a truncated prolate spheroid with the mitral valve at 
the base (superior end) and apex at the inferior end. Papillary muscles connect the 
inner surface of the LV wall to the cusps of the mitral valve via the chordae tendinae 
and contract to prevent inversion of the valve. The LV wall is composed of three layers: 
endocardium (inner layer), myocardium (middle layer), and epicardium (outer layer); 
the myocardium itself consists of sheets of cardiomyocytes (70% of volume) and 
interstitial components (30% of volume).  
Passive and active LV biomechanics are inherently dependent on the myocardial fibre 
orientation since myofibres contract and stretch along the fibre direction. Viewed from 
the apex, the fibres wrap the LV in a helical pattern and vary approximately linearly 
from epicardium (right handed helix) to endocardium (left handed helix). Although 
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
5 
 
assumed in literature, the fibres are generally not parallel to the LV wall (Holzapfel and 
Ogden, 2009). The fibre angle with respect to the LV wall is known as the transverse 
angle and the angle with respect to the circumferential plane is known as the helical 
angle. Helical fibre angles vary from approximately +60° to -60° from endocardium to 
epicardium (Streeter Jr et al., 1969) and transverse angles from -10° to +10° from apex 
to base. Transverse angles, however, are 0° at the epicardial and endocardial surfaces 
(Bovendeerd, 2008). 
a) 
 
b) 
 
Figure 2-2: a) Blunt dissected LV showing helical myofibres and b) Cross-section of myocardium 
with helical (αh) and transverse (αt) angles depicted (Bovendeerd, 2008) 
2.1.2. Physiology 
The heart functions as a mechanical pump, circulating blood through the pulmonary 
and systemic circulatory systems. The average human heart beats 72 times per minute 
and will beat approximately 2.5 billion times during one’s lifetime. Blood flows in 
through the inferior and superior vena cava and is collected in the right atrium. It then 
moves through the tricuspid valve into the RV. Blood is ejected from the RV through 
the pulmonary valve and circulated to the lungs for oxygenation. It returns to the heart 
passing through the left atrium. During passive filling, the blood enters the LV through 
the mitral valve. And finally, the blood is pumped out of the LV through the aortic valve 
where it circulates throughout the body. The LV needs to support a higher pressure 
than the RV in order to pump the blood throughout the entire body, as opposed to the 
pulmonary circulation, and is therefore, the largest chamber and has the thickest walls.   
Knowledge of the four distinct phases to the LV cardiac cycle is pertinent to effective 
analysis of the mechanical function to be studied. During isovolumetric contraction, 
which marks the beginning of systole, the muscle contracts due to ventricular 
depolarization beginning at the sinoatrial node. The pressure increases while volume 
within the ventricle remains constant until the LV pressure exceeds aortic pressure 
and the aortic valve opens. In the second phase, the pressure then remains constant 
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while blood is expelled from the LV into the aorta during ejection. In the third phase, 
termed isovolumetric relaxation, pressure decreases and volume remains constant 
until LV pressure falls below left atrial pressure. Starting at that time point, blood flows 
from the atrium to the ventricle during filling, i.e. the fourth phase. At the completion of 
which, the next cardiac cycle begins. The first two phases, isovolumetric contraction 
and ejection, make up systole while isovolumetric relaxation and filling phases 
compose diastole (Suga and Sagawa, 1974, Burkhoff et al., 2005).The pressure-volume 
loop shown in Figure 2-3 outlines the four phases of the LV cycle.  
 
Figure 2-3: LV Pressure-Volume Loop 
2.1.3. Cardiac Functional Parameters 
Measurable cardiac parameters used in clinical as well as research settings include 
blood pressure, volume and flow rate, particularly in the four cardiac chambers. LV 
end-diastolic (ED) and end-systolic (ES) volumes, LV mass, and ejection fraction (EF) 
are often used to gauge functional cardiac performance on a macro scale. For example, 
an inflated end-diastolic volume (EDV) can signify LV dilation (Holmes et al., 2005) and 
a depressed EF can be indicative of increased systolic stress and LV hypertrophy (Nagy, 
2001), both present in post-infarction remodelling. EF, see Eq. 2.1, is considered to be 
one of the most meaningful measures of LV pump function and can be determined from 
data obtained using non-invasive imaging techniques: 
 	 = 	  	= 	 −   (2.1)  
 
where SV is stroke volume  and ESV is end-systolic volume. Effective arterial elastance 
(Ea), the ratio of end-systolic pressure (PES) to stroke volume (SV), expressed as:  
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 	 = 
  (2.2)  
 
is a useful method of assessing arterial load and its impact on the LV. In particular, Ea 
can highlight pulsatile loading due to hypertension or aging (Kelly et al., 1992). The 
end-diastolic and end-systolic pressure volume relationships (EDPVR and ESPVR, 
respectively) are visualised by plotting the left ventricular pressure versus volume for 
the diastolic and systolic phases. The EDPVR describes the passive filling and thus the 
passive properties of the LV. The slope of the EDPVR at any point is the reciprocal of 
the ventricular compliance. The ESPVR describes the maximum pressure that can be 
developed in the LV for any given LV volume. The slope of the ESPVR represents the 
elastance (Ea), described above.  
 
Figure 2-4: Graph of LV pressure versus LV volume showing pressure-volume (PV) loops, end-
systolic pressure volume relationship (ESPVR) and end-diastolic pressure volume relationship 
(Burkhoff et al., 2005) 
Fractional shortening (FS), measuring the change in diameter of the LV between the 
contracted and relaxed states, can provide detailed micro scale information about the 
contractile abilities of local myocardium. FS is calculated as: 
  =  −   (2.3)  
 
where dED and dES are the ED and ES LV diameters, respectively. Patients with LV 
hypertrophy may exhibit normal cardiac function based on EF-systolic stress relations 
and macro scale functional parameters, but an abnormal or diminished FS (Aurigemma 
et al., 1995). Measuring local FS gives a more detailed image of cardiac function in 
various areas of the heart. 
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 In addition to functional parameters, myocardial mechanics such as wall motion, 
thickening and strain can provide useful information on the dynamic system of the 
heart and LV (Frangi, 2001). 
2.2. Myocardial Infarction of the Left Ventricle 
An MI is caused by restriction of blood supply to a particular region of the myocardium 
usually caused by plaque build-up in the coronary arteries. Atherosclerosis, thickening 
and hardening of the arterial walls, is the progressive accumulation of lipids and 
fibrous elements typically protected by a fibrous cap. Atherosclerotic regions in a 
coronary artery can grow large enough to restrict blood flow to myocardium. Sudden 
rupture of the fibrous cap causes platelet aggregation and thrombus formation leading 
to a rapid occlusion of the artery (Hirai et al., 1989).  
 
Figure 2-5: Occluded coronary artery causing a myocardial infarction (MedicineNet, 2004) 
A blocked coronary artery prohibits the perfusion of oxygen and causes transformation 
of the myocardium from an active to a passive material. The loss in contractility of the 
ischaemic myocardium immediately affects the heart’s ability to pump an adequate 
amount of blood to the systemic circulatory system. Consequently, various molecular, 
cellular and interstitial changes occur in the healthy as well as infarcted myocardium 
resulting in changes in shape, size and function in an attempt to maintain homeostasis. 
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There are four primary phases of change after a single, non-reperfused myocardial 
infarction: 1) acute ischaemia, 2) necrosis, 3) fibrosis and 4) remodelling. Table 2-1 
highlights the major ventricular changes that occur during each of the four phases 
post-infarction (Holmes et al., 2005). 
Table 2-1: Four phases of ventricular healing post-infarction (Holmes et al., 2005) 
Phase of 
Healing  
Onset  End  Time 
Frame 
(Humans) 
Structural 
Changes  
Infarct 
Mechanics 
Ventricular 
Function   
Acute 
Ischaemia  
Occlusion 
of 
coronary 
artery  
Infarct 
stiffening   
Infarction 
– hours 
Disruption 
of 
structural 
proteins  
Passive 
myocardium 
Impaired 
systolic 
function  
Necrosis  Infarct 
stiffening  
Collagen 
formation  
hours - 7 
days 
(Fishbein 
et al., 
1978) 
Edema, 
necrosis, 
and 
degradation 
Increased 
stiffness and 
strength; 
infarct 
expansion 
Impaired 
systolic 
function 
Fibrosis  Collagen 
formation 
Decreased 
collagen 
formation 
7 - 28 
days 
Increase in 
collagen 
content 
(scar 
formation) 
Maximum 
stiffness 
Impaired 
diastolic 
function 
Remodelling  Decreased 
collagen 
formation 
  28 days -  Scar 
shrinkage 
and 
collagen 
cross-
linking 
Decrease in 
stiffness; 
scar 
an/isotropy 
Improved 
LV function 
 
In the acute phase post-MI, loss of blood supply causes infarcted myocardium to 
become passive, losing contractility and impairing systolic function. Necrosis, or cell 
death, occurs when the infarct begins to stiffen. During this phase, stiffness and 
strength increase, due to oedema, and the infarct expands. In the third phase post-MI, 
fibrosis, collagen formation begins to build scar tissue in the infarcted region and the 
infarct reaches maximum stiffness. At this point, systolic function of the LV is partially 
restored but diastolic function is impaired due to inhibition of adequate LV filling. And 
finally, in the remodelling phase, collagen formation decreases (but does not cease), 
decreasing infarct stiffness and causing scar shrinkage. LV function improves overall 
during the remodelling phase (Holmes et al., 2005). Despite this fact, ventricular 
remodelling is accepted to be a critical determinant in the progression towards heart 
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failure as the infarcted wall becomes thinner and LV dilation continues (Cohn et al., 
2000, Pfeffer and Braunwald, 1990).  
The effects of infarct mechanical properties on ventricular performance differ not only 
during each phase of healing but also during systole and diastole: A compliant infarct, 
during the acute and necrotic phases, impairs systolic ejection. The myocardium 
stretches during systole thereby dissipating work of the non-infarcted myocardium 
and reducing the ventricular pump function. Following a MI, LV dilation increases 
through a positive feedback loop with LV wall stress (Pfeffer and Braunwald, 1990). As 
stress in the infarct region increases due to dilation, cardiomyocytes lose the ability to 
shorten effectively, leading to further stretching. Conversely, a stiff infarct region may 
impair the diastolic filling by reducing the overall ventricular compliance. The complex 
nature of accommodating systolic as well as diastolic function throughout the phases of 
remodelling make development of new therapies and treatments a difficult task. 
Myocardial infarctions vary drastically from patient to patient and the severity of an MI 
is often classified according to size – microscopic, small (<10% of the LV wall volume), 
medium (10 – 30% of the LV wall volume) or large (>30% of the LV wall volume) – as 
well as location (anterior, lateral, inferior, etc.) (Antman et al., 2000). It is suggested 
that mortality and morbidity increase drastically when more than 20% of the LV is 
infarcted (Miura and Miki, 2008).  
2.3. Current Post-Infarction Therapies 
2.3.1. Pharmaceuticals 
Various pharmaceuticals, often the first form of treatment, are administered to patients 
post-MI include angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic 
blockers. ACE inhibitors block the conversion of angiotensin I to angiotensin II, a 
vasoconstricting agent which also stimulates ventricular remodelling of the heart post-
MI among other things. Therefore, ACE inhibitors act as vasodilators, lowering arterial 
resistance and increasing venous capacity, as well as limit hypertrophy and slow the 
progression towards HF. In a systematic overview of patient data after administration 
of ACE inhibitors, Flather et al. (2000) showed that ACE inhibitors reduce the risk of 
heart failure and recurrent infarctions post-MI.  
Beta-blockers reduce the effects of epinephrine and other stress hormones and are 
administered both as cardioprotection after an MI and as a treatment for hypotension. 
Beta-blockers reduce mortality in post-MI patients by up to 40% (Gottlieb et al., 1998). 
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These results are not, however, associated with a reduction in ventricular remodelling 
or any long-term effects of cardiac mechanics.  
Aldosterone receptor antagonists (ARAs) have been proposed as a replacement for 
ACE inhibitors which lose their effect 8 months after administration. In two studies, 
ARAs displayed positive results in reducing ventricular hypertrophy as well as 
reducing morbidity and mortality in patients post-MI (van der Horst et al., 2007, Rocha 
and Stier, 2001).  
As with any drugs, patients can experience adverse reactions such as hypotension, 
headache, dizziness, fatigue, nausea and renal impairment with all three treatments. In 
addition, some patients still exhibit signs and symptoms of heart failure after achieving 
optimal doses of pharmacotherapy.  
2.3.2. Mechanical Stabilization 
Another alternative for post-infarction therapy is mechanical stabilization of the LV 
using a heart splint or Acorn cap. The heart splint is designed to decrease LV wall 
stress by changing LV shape, improving contractile function in dilated hearts, common 
in post-infarction remodelling. Specifically, the shape is changed by placing three 
splints perpendicular to the LV long axis, pulling the LV walls inward and creating a 
symmetric bilobular shape (see Figure 2-6). 
 
Figure 2-6: LV splint (Large, 2007) 
After successful placement of the splints into canine hearts with induced dilated 
cardiomyopathy, a 30% reduction in ED wall stress and 39% reduction in ES wall 
stress were observed (Takagaki et al., 2001). Another canine study also showed a 
significant increase in EF from 19% to 36% acutely and 39% after one month of splint 
implantation (McCarthy et al., 2001). A second form of mechanical stabilization is the 
Acorn Cardiac Support Device (Figure 2-7) which fits snugly around both ventricles 
and is sutured to the atrioventricular groove (Sabbah, 2003). It is designed to reduce 
ventricular dilation and LV stress. Although a more invasive approach than 
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pharmaceutical therapy, cardiac support devices directly address the ventricular 
changes that occur as a result of post-infarction remodelling.  
 
Figure 2-7: Acorn cardiac support device (CorCap) 
2.3.3. Cell Therapy 
A third therapy option is injection of myoblasts, embryonic progenitor cells that give 
rise to myocytes, into the infarcted myocardium to promote re-growth of muscle tissue. 
In a study comparing rats with non-infarcted hearts, infarcted hearts plus sham 
injection, and infarcted hearts plus skeletal myoblast cell injection, infarctions were 
induced by one hour coronary ligations followed by reperfusion and cells were injected 
into the infarct one week following MI. Hearts with cell injections exhibited attenuation 
of ventricular dilation compared with MI hearts that did not receive cell therapy. Post-
MI in vivo exercise capacity and ex vivo LV systolic pressures improved for the cell 
injected group (Jain et al., 2001). In a clinical trial, an intracoronary injection with 
either placebo or bone marrow-derived stem cells was given to patients post-MI. As a 
result, LV EF increased for patients with cell therapy. In addition, cell infusion reduced 
infarct size by 28% and aided a better recovery of regional systolic function (Janssens 
et al., 2006).  
In other studies, stem cells were combined with an extracellular matrix including 
growth factors prior to injection into infarcted mouse hearts. Histological results from 
Kofidis et al. (2005) showed that the liquid injectable tissue solidified at body 
temperature, preserving ventricular geometry and function. Despite positive results on 
LV function, cardiomyocyte differentiation is extremely inefficient and is highly 
dependent on the microenvironment. Beyond differentiation, cell death and immune 
rejection remain obstacles to tissue regeneration (Laflamme et al., 2007). Therefore, it 
is uncertain whether these positive results are due to the injected cells and cellular 
activity or the supportive mechanical and material properties of carrier medium. 
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Therefore, recent research, including this study, is aimed at determining the 
mechanical effect of the injected medium on LV mechanics.  
2.3.4. Biomaterial Injectates 
Biomaterial injection aimed at preventing heart failure involves incorporating the 
material completely within the heart wall where it acts as a bulking agent. Materials 
are delivered through injection into strategic points in and around the infarct. Both 
biological and synthetic materials have been investigated for post-infarct injection 
therapy. Biological materials, such as alginate, fibrin, gelatin and collagen, are innately 
biocompatible and readily accessible to clinicians. Synthetic materials, such as self-
assembling peptides and synthetic hydrogels, however, can be designed to meet 
specific material objectives such as stiffness, porosity and degradation (Nelson et al., 
2011).  
Positive in vivo results have been seen using biological injectates such as alginate, fibrin 
and gel derived from porcine small intestinal submucosa (SIS). Injecting alginate 
augmented LV wall thickness resulting in improvement of LV FS and prevention of LV 
dilation over 5 weeks. Although fibrin injected infarcted hearts displayed a similar 
initial improvement in cardiac performance and restoration of LV wall thickness, there 
was deterioration in fractional shortening observed at 10 weeks post infarction. Both 
alginate and fibrin, however, stimulated neovascularisation in the infarct region (Yu et 
al., 2009). Injection of SIS gel, commonly used to promote accelerated wound healing, 
into infarcted mice hearts led to preservation of ES LV geometry and an improvement 
of cardiac contractility, determined by echocardiography at 2 and 6 weeks (Okada et 
al., 2010). Research on injection of self-assembling peptides has shown that the fibrous 
structure encourages host cell infiltration which could be beneficial for myocardial 
repair post-infarction. However, its immediate effect is a decline in FS (Davis et al., 
2005).  
Using an in vivo MI rat model, researchers in the Cardiovascular Research Unit have 
studied the effect of injecting a synthetic biomaterial into the ischaemic myocardium. 
In the initial study, the left anterior descending coronary artery was ligated and non-
degradable polyethylene glycol (PEG) hydrogel was immediately injected into the 
infarcted region. After four weeks, the increase in LV ED diameter normally seen in 
post-infarction remodelling was drastically reduced (43%, P < 0.05) and wall thinning 
was prevented completely. Therefore, the injection of the hydrogel lessened 
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pathological remodelling in the immediate post-infarction healing stage (Dobner et al., 
2009). 
 
Figure 2-8: Micrograph of Masson's trichrome stained infarct at 4 weeks post-infarction for saline 
(a) and PEG hydrogel injected heart (b) (Dobner et al., 2009) 
A similar study was conducted injecting an enzymatically-degradable PEG hydrogel 
seven days after infarction, following necrosis of the ischaemic myocardium, in order 
to compare results to the initial study using non-degradable PEG hydrogel. Results of 
delayed delivery showed an increase in scar thickness and FS as well as less dilatation 
of the infarct region during systolic contraction compared with the saline control and 
immediate injection cases (Kadner et al., 2012). 
Although positive results have been observed with numerous biomaterials, a PEG 
hydrogel is ideally suited for post-infarct injection because its material characteristics 
such as elasticity, bulk modulus, permeability and degradation rate can be altered 
relatively easily during the gelation process (Lin and Anseth, 2009). Subsequently, it 
can be adapted to provide the best structural support for the infarct area during the 
integral stages of remodelling.  
2.4. Cardiac Imaging 
Cardiac imaging is essential for diagnosing and monitoring the progression of heart 
disease post-MI as well as analysing results of various therapies on the heart. Current 
widely used cardiac imaging modalities include echocardiography, magnetic resonance 
imaging (MRI) and computed tomography (CT). These imaging techniques are not only 
used as diagnostic tools but also for qualitative and quantitative analysis of ventricular 
and cardiac performance. Echocardiography, utilizing traditional ultrasound, is a 
common form of cardiac imaging. Although a traditional echocardiogram is performed 
on the surface of the chest, a transesophageal echocardiogram, unobstructed by the 
ribs and lungs, can provide a more detailed image of the heart. Real-time 3D 
echocardiography can give an immediate indication of relative cardiac function by 
measuring ratio between the ventricles in systole and diastole, provide quantitative 
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information such as LV volume and mass and allow for wall motion analysis (Frangi, 
2001). Real-time 3D transesophageal echocardiography can identify various cardiac 
diseases including mitral stenosis, hypertrophic cardiomyopathy and endocarditis 
(Pothineni et al., 2007).  
MRI, an established form of cardiac imaging, supplies anatomical and functional 
information about the heart without the use of invasive techniques. Due to the large 
imaging window and high resolution, its cardiac clinical and research applications are 
numerous and diverse. In two studies by Heiberg et al., an automated method to 
quantify myocardial infarction area using MR images was developed. The first utilised 
contrast enhanced MRI while the latter additionally accounted for partial volume 
effects (i.e. thinning of the myocardium) (Heiberg et al., 2005a, Heiberg et al., 2008). 
MRI is also used for cardiac reconstruction which involves segmenting the endo- and 
epicardial surfaces from short axis slices and reconstructing them in finite element 
(FE) software.  
CT, an imaging technique that compiles a large series of 2D x-ray images, can provide 
extremely detailed 3D images of myocardium and the vasculature but loses resolution 
as a patient’s heart rate increases due to motion artefacts (Hong et al., 2001). 
Therefore, it is less commonly used in patients with arrhythmias and fast heart rates. 
In a study by Ohnesorge et al. (2000), however, electrocardiographically (ECG) gated 
multi-section spiral scanning CT was used to image patients’ hearts with severe 
fibrillations. In addition, dual-source CT has also been proven to offer a more robust 
diagnostic image quality over a wide range of heart rates (Johnson et al., 2006). These 
studies have shown that CT can be a viable modality for cardiac imaging and diagnosis 
of CVD in patients with irregular heart rhythms.  
2.5. Finite Element Method 
The mechanics of complex structures and materials often cannot be described using 
purely analytic methods. In these cases, numerical methods using a computer become 
useful. Numerical modelling is the process of solving the equations describing a 
physical process using a step-wise approximation. The equations are designed to 
represent the inputs, outputs, internal states of the process and the interaction 
between each. Solutions are obtained by performing iterations at each step until the 
numerical answer satisfies all the equations being used. Verification is an integral part 
of numerical modelling since models often use several parameters to describe a 
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physical process. Previously observed results should be used to verify the accuracy of 
numerical models and tune the parameters against the observed results.  
FE, finite difference, boundary element and finite volume are a few methods of 
numerical modelling which involve subdividing the physical area of interest into 
smaller fragments and treating these in a simplified manner. The FE method, used in 
this thesis, will be described further. 
The finite element method (FEM) can be traced back to a paper by Courant (Courant, 
1943) and since then, it has become one of the most widely used techniques in 
computational biomechanics. It has greater geometrical flexibility than other numerical 
methods. Solid mechanics problems generally take the form of systems of partial 
differential equations (PDE) defined in terms of the spatial coordinates and time. FEM 
is useful for solving PDEs in cases involving complex geometries, boundary conditions, 
nonlinear material behaviour and contact. A solution is found by either eliminating the 
differential equation completely (steady state problems) or rendering the PDEs into an 
approximation system of ordinary differential equations (ODE) which are then 
numerically integrated using standard techniques such as Euler’s method.  
One defining feature of FEM is the discretisation of continuum problems into a mesh of 
simpler shapes, such as rods for 1D problems, triangles and quadrilaterals for 2D 
problems and tetrahedrals and hexahedrals for 3D problems. The vertices and 
specified points of the elements are known as nodes. Another key feature of FEM is that 
all governing equations are represented in integral form. The integral over the entire 
domain is equal to the sum of the integral over each subdomain. Therefore, the FEM 
provides a means for solving and assembling a numerical problem.  
The FEM typically involves the following steps (Usyk, 2002):  
1. Formulate the weighted residual 
2. Integrate by parts or use the Green-Gauss theorem for vector or tensor 
variables 
3. Discretise the problem into elements and the dependent variables using finite 
expansions of basis functions 
4. Derive the FE equations by substituting the dependent variable approximation 
in the weighted residual integral 
5. Compute the element stiffness matrices and load vectors by integrating the 
equations over each subdomain 
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6. Assemble the global stiffness matrix and load vector by adding element 
matrices and load vectors into a global system of equations 
7. Apply essential boundary conditions eliminating the rows and columns 
corresponding to constrained nodal degrees of freedom from the global 
stiffness matrix to achieve the constrain-reduced global stiffness matrix 
8. Solve the global equations for unknown nodal dependent variables using 
standard algorithms 
9. Evaluate element solutions by interpolating dependent variables and 
computing their derivatives 
10. Visualise and post-process the solution graphically 
11. Test for convergence, refine the FE mesh and repeat solution 
In the general case, a function u satisfies a set of PDE’s: 
  = 	 ⋮  = 0 (2.4)  
 
Over a domain Ω, subject to appropriate boundary conditions: 
  = 	 ⋮  = 0 (2.5)  
 
The FEM approximates the solution   in the form: 
 	−	 = 	 !  (2.6)  
 
Where  are basis functions prescribed in terms of independent variables such as 
spatial coordinates. Some of the parameters    are unknown. The FE solution is 
approximated inside the elements by shape functions which can take on a number of 
forms, including polynomial expressions such as " =  + $" + %" + "& +⋯where a, b, c, d, ... are estimated to obtain a best approximation of  the field variable ". 
Figure 2-9 illustrates the way a piecewise linear interpolation can approximate an 
exact continuous solution. Continuity of field variables is usually enforced across 
neighbouring elements and the accuracy of a solution increases with higher order basis 
functions.  
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Figure 2-9: Piecewise approximation of a function 
Lagrange and Hermite basis functions were both used in the modelling for this thesis. 
The eight three-dimensional trilinear Lagrange basis functions are constructed from 
the products of the one-dimensional linear function and correspond to the eight nodes 
of a trilinear brick element (Figure 2-10). A three-dimensional tricubic Hermite 
element requires eight derivatives per node, resulting in a large number of basis 
functions. Although computationally simpler, Lagrange basis functions only provide C0 
continuity of  across element boundaries. Therefore, to preserve continuity of the 
derivative of  as well, Hermite basis functions are necessary. 
 
Figure 2-10: 8-noded three-dimensional isoparametric (trilinear brick) finite element 
The discretisation of a domain results in a patchwork of elements that interconnect to 
form the geometry. Selection of element type and number of nodes depends on the 
complexity of the geometry. The number of elements in the mesh and their size depend 
on the degree of spatial variation of the field variable in the problem. If large variations 
are expected, a greater number of small elements should be used to approximate the 
field variable. In addition, a more refined mesh with more elements can increase the 
accuracy of the final solution. As the number of nodes and elements increases, results 
typically converge to the true solution of the problem. However, meshes with a greater 
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
19 
 
number of nodes and elements are computationally expensive and often not feasible. 
Therefore, the amount of refinement depends on the computational resources and the 
acceptable level of numerical accuracy.  
2.6. Computational and Numerical Modelling of the Heart 
Cardiac modelling can be a purely solid mechanics problem using FEM while some 
more complex models involve modelling the fluid structure interaction (FSI) between 
the blood flow and heart walls. FSI combines finite volume methods, often referred to 
as computational fluid dynamics (CFD) and FEM to investigate the mutual mechanical 
effects between the heart and blood. For this thesis, the LV was modelled using solid 
mechanics only and not FSI.  
Modelling LV mechanics has four major components: ventricular geometry and 
structure; pressure and displacement boundary conditions; partial differential 
equations governing the conservation of mass, momentum and energy; and the 
constitutive laws that describe mechanical responses of resting and contracting 
myocardium.  
2.6.1. Cardiac Modelling Software 
There are many software packages available with capabilities for cardiac modelling. 
Abaqus FEA (D S Simulia. ©DassaultSystemes, Providence, USA, 2007) is a suite of 
software applications which has four core uses: computer-aided engineering, CFD, 
nonlinear transient dynamic and quasi-static analysis and general-purpose finite 
element analysis (FEA). Abaqus has been used in a number of studies involving cardiac 
mechanics. For example, Ratcliffe et al. (1998) researched the effect of ventricular 
volume reduction surgery in a dilated LV using Abaqus’s nonlinear finite element solver 
to determine deformations in myocardium and ventricular volumes. One limitation is 
that Abaqus, at present, does not allow for electromechanical coupling necessary for 
cardiac modelling without the implementation of user-defined subroutines.  
FEBio (University of Utah, Salt Lake City, Utah, 2010), an open-source nonlinear FE 
solver specifically designed for biomechanical applications, offers modelling scenarios, 
constitutive models and boundary conditions that are relevant to many research areas 
in biomechanics. Its primary application since development is in the area of 
musculoskeletal research. However, it has shown promise for application to cardiac 
FEA since it has the capability of modelling active muscle contraction. In addition, it has 
porous material models to accurately describe soft tissues such as myocardium. The 
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only past application of FEBio within cardiac mechanics was its use in proving the 
accuracy of a fast porous visco-hyperelastic soft tissue model (Marchesseau et al., 
2010). 
Continuity (UCSD, San Diego, California, 2010), a FE software freely available, was 
developed at the University of California San Diego specifically for the application to 
cardiac mechanics. Where FEBio requires external meshing software, all steps of 
cardiac modelling can be carried out in Continuity including image segmentation, 
model generation and FE analysis. It is particularly useful for solving problems in 
biomechanics, biotransport and electrophysiology. Continuity has been used to solve 
multiple multi-scale models for cardiac applications including a study on biventricular 
pacing and scar size on LV regional and global function (Kerckhoffs et al., 2009). 
Abaqus, FEBio and Continuity provide various constitutive models that can be applied 
to myocardium. However, Continuity also has pre-established circulatory and 
electrophysiology load models. Continuity was chosen as the primary candidate FEA 
software for this thesis due to its comprehensive capabilities and relevancy to the area 
of cardiac biomechanics. 
2.6.2. Reconstruction of Cardiac Geometries 
MRI and CT data have both been used for cardiac reconstruction due to their high 
resolution. Most often, cardiac geometry is obtained by segmenting the epi- and 
endocardial surfaces from a series of short-axis images and assigning spatial 
coordinates to points along the contours. These coordinates are then imported to FE 
software to create a mesh model of the heart. Various automated and semi-automated 
segmentation algorithms have been developed to create efficiency and precision when 
defining contours. Common algorithms utilise user and pre-defined threshold values as 
well as level set methods (Paragios, 2003). However, signal loss due to blood flow and 
partial volume effects (González Ballester et al., 2002) and variation of grey values 
make accurate automated segmentation a difficult task. Kaus et al. (2004), following 
similar studies, incorporated multiple a priori information sources into a fully 
automated deformable model segmentation technique. Prior information sources 
included an inter- and intra-subject shape variation and spatial relationships which 
were used to define constraints.  
There are, however, some drawbacks of MR and CT based cardiac tissue reconstruction 
including the still somewhat limited spatial resolution. And despite near automation of 
the process, there are still challenges in accurately segmenting the images. One major 
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drawback of MR-based cardiac models is that they do not include the atria, papillary 
muscles, trabeculae or segmentation of tissue for different cell populations. Some 
studies have investigated incorporating histological validation of MRI and DTMRI to 
produce a more comprehensive cardiac model based on geometry from MRI and 
histological information on cell types, intracoronary arteries, papillary muscles, fibre 
angles, etc. (Burton et al., 2006).  However, the majority of FE cardiac models disregard 
the smaller features of the cardiac tissue as these would increase computation time and 
are not necessary for many applications. 
Segment (Lund University and Medico AB, Lund, Sweden), an open-source software for 
cardiovascular image analysis, allows for automatic segmentation of the LV based on a 
fully deformable model. It can be used with various imaging modalities including MRI, 
CT, positron emission tomography (PET) and single photon emission computed 
tomography (SPECT). The segmentation method utilises an enhanced edge detection 
scheme that includes temporal and a priori anatomical information (Heiberg et al., 
2005b). The procedure also allows for identification of both endo- and epicardial 
surfaces as well as disqualification of papillary muscles when identifying the 
ventricular wall. ITK-SNAP (Yoo et al., 2002) another freely available image analysis 
software package, uses a semi-automated level set method of segmentation for various 
anatomical structures in the body. Although it has a wider range of applications than 
Segment, ITK-SNAP requires the user to accurately specify numerous parameters that 
affect segmentation (Yushkevich et al., 2005). For this Master’s thesis, Segment 
provided a more efficient method of LV segmentation. 
After segmentation, spatial coordinates defining contours from each short-axis slice are 
imported into FE software for volumetric reconstruction. Continuity uses a least 
squares fitting method that applies weights to data points and smoothing weights to 
minimise the root mean square (RMS) error between the interpolated and original 
measured coordinate. Past computational studies have modelled the LV as various 
shapes including a sphere, spheroid (Beyar and Sideman, 1984), thick-walled cylinder 
(Arts et al., 1979, Arts et al., 1982) and truncated ellipsoid. A prolate spheroid, or 
truncated ellipsoid, provides the most grossly realistic shape to model the LV. The 
anatomic geometry of the LV can, therefore, be best described using the prolate 
spheroidal coordinate system (Vetter and McCulloch, 1998). Cartesian coordinates are 
shown in Figure 2-11 in terms of the prolate spheroidal coordinates, Λ, Μ and Θ.  
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With mesh nodes and elements appropriately fit to the cardiac or LV geometry, FEA 
can be performed in FE software such as Abaqus FEA, FEBio and Continuity6.3 to 
determine stresses and strains within the myocardium. 
2.6.3. Modelling Myofibre Orientation 
Since the greatest stress generally occurs along fibre direction, a one-fibre model that 
wraps around the entire LV can be used to describe fibre orientation when modelling 
cardiac biomechanics (Arts et al., 2003). Other fibre models from in vitro 
measurements in animals such as rabbits, pigs and dogs provide more insight into the 
transmural and longitudinal fibre orientation gradients through the LV (Omens et al., 
1991). More recent patient-specific cardiac modelling applies fibre angles measured 
from human diffusion tensor MRI (DTMRI) images (Rohmer et al., 2007) which give a 
much more accurate representation of fibre orientations in the human LV. Although the 
trend in fibre variation throughout the LV is similar for animals and humans, there are 
slight variations in fibre angle magnitude which can affect the resulting model. There is 
still room for improvement in fibre angle measurement from DTMRI since trabecular 
and papillary muscles cause low resolution of DTMRI on the endocardial surface. 
Depending on the constitutive and active models applied, LV fibre angles in a FEM can 
greatly affect the behaviour of both diastolic filling and systolic contraction. 
2.6.4. Cardiac Constitutive Models 
Passive myocardial material properties and constitutive models have been mainly 
described by a) stress-strain relationships from experimental tests of myocardium 
under prescribed loading conditions and b) estimation of material properties by 
matching the model deformation solution and experimentally measured myocardial 
deformation under prescribed loading conditions (semi-inverse method) (Watanabe et 
al., 2004).  
Figure 2-11: LV prolate spheroidal geometry with parameters Λ, Μ and Θ 
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The structure and organisation of cardiac muscle fibres and extracellular matrix result 
in the macroscopic symmetry and mechanical properties and function of heart tissue. 
Some researchers have attempted to deduce material properties from the EDPVR and 
wall geometry. While this method of analysis can provide some information on overall 
stiffness, it is not useful for studying regional cardiac mechanics or relating material 
behaviour to the three-dimensional structure of the wall.  
Biaxial tensile tests of excised tissue showed that passive myocardium is anisotropic 
and stiffest in the fibre direction, and hence, can be modelled as transversely isotropic 
(i.e. isotropic in the plane normal to the fibre direction). Results from biaxial testing 
also illustrated that the nonlinear, viscoelastic properties of myocardium are 
approximately pseudo-elastic (Demer and Yin, 1983). Myocardium, therefore, is often 
modelled as a finite hyperelastic material, where the components of the second Piola-
Kirchhoff stress are related to the Lagrangian Green’s strain through the pseudo-strain 
energy, W. The functional form of the W is often estimated by curve-fitting 
experimental measurements which complicates the interpretation of parameters and 
limits the model to one condition. However, determining W directly from the data 
using a specifically designed biaxial test resulted in the following polynomial function: 
( = %) − 1 + %) − 1& + %&+ − 3 + %-+ − 3) − 1+ %.+ − 3 
 
(2.7) 
This study also revealed an interaction between the isotropic and anisotropic terms 
(Humphrey et al., 1990).  
However, with biaxial testing alone, there is uncertainty as to how the properties of 
isolated tissue are related to properties of the intact ventricular wall. To address this 
issue, Guccione et al. (Guccione et al., 1991) determined material parameters through a 
semi-inverse method by simultaneously inflating, stretching and twisting a FE thick-
walled cylinder to obtain epicardial strains measured in isolated arrested canine 
hearts. A transversely isotropic strain energy function was chosen based on the fibrous 
structure of the myocardium: 
 ( = 1201"23 − 1 (2.8)  
where 
 3 =	$4444 + $55677 + 88 + 78 + 879+ $45647 + 74 + 48 + 849 (2.9)  
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The transversely isotropic exponential strain energy function with new material 
parameters was a vast improvement from previous models (Guccione et al., 1991).  
Despite the success of the transversely isotropic model in predicting LV strain and 
stresses, there is evidence from simple shear tests (Dokos et al., 2002) to suggest that 
ventricular myocardium is locally orthotropic since there is a distinct stiffness in the 
cross-fibre as well as fibre direction. Under tension, muscle fibres are elongated and 
the primary load lies in the fibre direction. During compression, fibres buckle and the 
collagen network extends laterally to bear the load as illustrated in Figure 2-12.  
 
Figure 2-12: Myofibre and collagen arrangement in the a) unloaded state, b) tensile state (fibre 
extension) and c) compressive state (collagen elongation) 
The following orthotropic strain energy function has been proposed which takes into 
account the cross-fibre stiffness (Holzapfel and Ogden, 2009): 
  =  2$ 1"2:$+  3; #   2$ <1"2:$+-	  1;  1=>4,8
#  482$48 @1"26$48+A	48
 9  1B 
 
(2.10)  
where a, b, af, as, bf, bs, afs and bfs are positive material constants. The equation consists 
of the isotropic term in I1, the transversely isotropic terms in I4f and I4s and the 
orthotropic term in I8fs. 
The assumption of incompressibility, reasonable for isolated myocardium, is not 
sufficient for the intact heart which can exhibit considerable tissue redistribution 
associated with changes in regional coronary blood supply (Usyk and McCulloch, 
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2003). In addition to physiologic inaccuracy, incompressible material models are 
difficult to converge. Therefore, in recent cardiac modelling, penalty functions have 
been added to strain energy functions in order to model the slightly compressible 
nature of myocardium (Usyk, 2002). 
Infarcted myocardium has previously been modelled using the same constitutive 
equations for passive healthy heart tissue but with varying stiffness depending on the 
time point after infarction, i.e. acute, necrotic, fibrotic, etc. (Bogen et al., 1980, Wall et 
al., 2006). Infarcted tissue is modelled as either fully passive (Wall et al., 2006) or with 
reduced calcium sensitivity (Mazhari, 1998). However, limited and contradictory 
information is available on anisotropy in healing myocardial infarcts. In one study, 
isotropic infarcts were observed in rats at 6 weeks post-infarction (Fomovsky and 
Holmes, 2010) while in another, anisotropy was seen in 6 week old sheep infarctions 
(Gupta et al., 1994). A DTMRI study of rat hearts 4 weeks post-infarction showed that 
relative anisotropy (RA) decreased by 37% in infarcted compared to healthy 
myocardium. However, the infarcted myocardium was still far from isotropic (Chen et 
al., 2003). 
2.6.5. Cardiac Mechanics 
When modelling cardiac mechanics, the LV pressure throughout a cardiac cycle is 
typically described either in relation to the aortic pressure (i.e. LV afterload) or as a 
ventricular pressure-volume relationship. Afterload models, including the two- and 
three-element Windekessel models (Stergiopulos et al., 1999), have received more 
attention and are more widely used in cardiac biomechanics than LV preload (i.e. 
ventricular filling pressure) models (Kerckhoffs et al., 2006). For contractile 
myocardial properties, variable elastance formulating the active cardiac force as 
function of muscle length and time (McCulloch, 2005), Hill-type models in which the 
active fibre stress varies with shortening or lengthening (Kerckhoffs et al., 2007, Suga, 
1990), and fully history-dependent models generally based on Huxley’s cross-bridge 
theory have been suggested (Arts et al., 1982, Nevo and Lanir, 1989).  
Cardiac electromechanics has been simulated with structurally and functionally 
integrated approaches combining cellular system models and anatomical multi-scale 
simulations (Hunter et al., 1998). At cellular level, the FitzHugh-Nagumo action 
potential equations (Kerckhoffs et al., 2006, Belik et al., 2004) and transmembrane 
ionic current models (FitzHugh, 1961, Nagumo et al., 1962), generally based on 
Hodgkin and Huxley (Hodgkin and Huxley, 1990) have been used as well as advanced 
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models considering transmural heterogeneity in electrophysiological properties (Belik 
et al., 2004, Noble and Rudy, 2001). 
2.6.6. Modelling an Infarct 
As discussed in Section 2.2, the ischaemic myocardium undergoes considerable 
changes during the four stages of remodelling following an infarction. Many groups 
have used FEA to model these changes in order to study the mechanical effects of a MI 
on LV and myocardial mechanics. In multiple models, the fibre angles in the infarct 
area were set to 0°, in line with the circumferential direction, in order to apply 
experimentally measured material properties relative to this direction (Walker et al., 
2008, Wenk et al., 2011b). In others, the fibre angles as well as fibre, cross-fibre and 
shear strain coefficients were kept constant throughout the healthy, border zone (BZ) 
and infarct regions (Kortsmit et al., 2012a, Guccione et al., 2001, Wenk et al., 2010).  
Ischaemic tissue becomes passive; therefore, in all previous studies, the infarct was 
modelled as either partially or fully non-contractile. In some models, contraction was 
limited in the BZ region surrounding the infarct. In others, the BZ was modelled 
identically to the remote healthy tissue. Very few FE models have incorporated 
geometric changes such as wall thinning and LV dilation, most prominent in later 
stages of post-MI remodelling. Some models that do account for geometric remodelling 
of the LV have created FE models based on MRI, CT or echocardiographic images of an 
infarcted heart (Wenk et al., 2011b). Most, however, use a similar LV geometry for 
healthy and infarcted cases. 
2.6.7. Biomaterial Injection 
Only three computational studies have been done on the mechanical effect of 
biomaterial injection (without stem cells) post-MI. In one study, single injection into 
anterior BZ, multiple BZ injections and single injection into the infarct zone were 
investigated with various injection volumes and a range of mechanical properties of 
the injectable biomaterial (Wall et al., 2006). A 3D FEM for large elastic deformation of 
ventricular myocardium (Costa et al., 1996) and a constitutive model representing 
passive and contractile anisotropic mechanical properties of healthy and impaired 
myocardium (Guccione et al., 1995) were implemented in a validated FE model of the 
LV previously proposed by Walker et al. (2005). Material injections were represented 
by local adjustment of the FE mesh (Figure 2-13). Contractility of the simulated 
injection site was reduced to account for the passive injected material. The latter was 
only required for injections in the functional BZ whereas the infarct zone did not 
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exhibit any active contractility. The effects of the injected material on the LV mechanics 
was assessed by predicting myocardial fibre stress and cardiac performance metrics 
such as ESPVR, EDPVR, EF, SV – end-diastolic pressure (EDP) relationships, and SV – 
EDV relationships. This study had important conclusions for acellular and cellular MI 
therapy approaches: 
• Small amounts of injected biomaterial (0.5-5% of total myocardial volume) can 
alter cardiac mechanics, reduce wall stress and affect cardiac performance 
measures. 
• Improvement in long-term ventricular mechanics may be achieved by passive 
reduction in local stress rather than adding contractile elements in the infarct 
zone. 
 
Figure 2-13: FE studies visualised: A) Single injection into the anterior border zone, B) Multiple 
injection sites into the peri-infarct border zone, and C) Multiple injection sites into the anterior and 
posterior sides of the infarct. Yellow regions are infarct; red regions are border zone, and green 
regions are remote (healthy) myocardium (Wall et al., 2006) 
The second computational tudy was concerned with the optimisation of the number 
and placement of hydrogel injections within the LV myocardium by minimising mean 
ED and ES myofibre stress and maximising LV SV. The LV was modelled as an 
axisymmetric truncated ellipsoid and the polymeric injections were represented as 
bolus spheres within the myocardium. The results were somewhat inconclusive and 
non-intuitive. When optimising for stress/strain and SV separately, minimising the 
mean ED and ES myofibre stress resulted in a 3 x 10 matrix of bolus injections (see 
Figure 2-14) while maximising the LV SV indicated a 2 x 1 matrix (not shown). 
However, changing the weighting factors and simultaneously optimising for both 
myofibre stress and LV SV resulted in a 3 x 6 matrix (not shown) of bolus injections 
totalling 3.24 mL of injected material (Wenk et al., 2009). 
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Figure 2-14: Example of five injection patterns generated during polymeric injection optimisation: 
(A) 2  x 5, (B) 1 x 1 (C) 3 x 1, (D) 3 x 10 and (E) 1 x 10 (Wenk et al., 2009) 
In a third computational study, Wenk et al. (Wenk et al., 2011b) developed two LV 
ovine FE models to compare the in vivo mechanical effect of treating an anterioapical 
infarct with the injection of a calcium hydroxyapatite-based tissue filler. The models 
were fit to echocardiographic data from a non-treated and treated sheep heart. The 
injection was geometrically modelled as an increase in wall thickness. The stiffness of 
the treated infarct region was then optimised until the infarct region was entirely 
akinetic. Diastolic filling and systolic contraction were simulated and FE analysis was 
used to measure fibre stress in the infarct and remote regions of the LV.  
The EF increased from 35% in the untreated infarcted case to 53% in the akinetic 
(treated) LV. In addition, the treated case exhibited lower ED and ES fibre stresses in 
the remote and infarct regions, as seen in Figure 2-15, compared to the untreated case 
(Wenk et al., 2011b).  
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Figure 2-15: Fibre stress distribution in the lateral wall of the dyskinetic left ventricle at (A) ED and 
(B) end systole. Fibre stress distribution in the lateral wall of the akinetic (treated) left ventricle at 
(C) ED and (D) ES. (Wenk et al., 2011b) 
The few computational studies that were done allow space for further research using 
computational mechanics to understand the effects of biomaterial injection into 
infarcted myocardial tissue. The first study (Wall et al., 2006) only took into account 
the geometrical changes of the LV and disregarded any changes in the material 
properties of the myocardium as a result of biomaterial injection. The second study 
(Wenk et al., 2009) sought to optimise the amount of injections but led to inconclusive 
results. The third study (Wenk et al., 2011b), although obtaining clear and positive 
results, assumed a treated infarct stiffness of more than 300 times that of the remote 
region of myocardium. This stiffness may or may not be realistic depending on the 
polymer being injected. This Masters research sought to complement and expand on 
these previous computational studies. 
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3. Methods 
3.1. Reconstruction of Human Left Ventricular Geometry 
Research-dedicated human cardiac MRI was available through Prof Ernesta Meintjes 
(UCT Division of Biomedical Engineering, Department of Human Biology) and Dr B 
Spottiswoode (Cape Universities Brain Imaging Centre, Stellenbosch University, 
Tygerberg). The MRI dataset (from a 36 year old male, 67 kg) consisted of 11 cine 
short-axis slices of a healthy human heart. The images were high resolution and 
represent the heart from base to apex at 17 time points over the full cardiac cycle. 
From these images, the endo- and epicardial contours were easily segmented to obtain 
ideal coordinates for LV reconstruction. 
Segment (Heiberg et al. 2010, http://segment.heiberg.se/) was used to segment the 
cardiac MRI dataset received from the UCT Division of Biomedical Engineering. The 
short-axis cardiac images were loaded as a 4D cine view and the contours of the endo- 
and epicardium were defined for each individual slice and time point using an 
automatic segmentation method based on an edge detection algorithm (Heiberg et al., 
2005a). The method, however, necessitated minor manual adjustment of the contours 
to omit valve openings and papillary muscles so that an accurate representation of the 
LV was obtained. Manual adjustment was done based on prior knowledge of LV 
geometry. By default, Segment selected 80 equidistant points along each contour to 
plot the geometry. With 11 slices per time point and 17 time points, Segment exported 
14,960 x-y coordinates representing the entire cardiac model in an image pixel-based 
coordinate system. The exported coordinates did not include z-axis values. However, 
the slice thickness (7 mm) and spacing (3 mm) were obtained from MRI header 
information of the DICOM image files and Segment indicated a scaling factor of 1.875 
mm/pixel. Therefore, the appropriate z coordinates were computed. For model 
creation, only the ES time point was selected as the reference time point representing 
the reference cardiac geometry for this study.  
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Figure 3-1: Example Patient MRI images from end-systolic time point with epicardial (green) and 
endocardial (red) contours of the LV segmented using Segment 
An algorithm was implemented in Octave (www.gnu.org/software/octave/), an open-
source high-level programming environment, to scale and shift the data to centre it on 
the apex and place the origin approximately 1/3 down from the base of the LV. The 
original MRI images weren’t aligned precisely along the short axis. To solve this 
problem, an additional program was implemented to rotate the data until the z-axis 
was approximately aligned down the midline of the LV. The scaled, shifted and rotated 
data was then loaded into Continuity. 
 
Figure 3-2: LV epicardial and endocardial contour data before (blue) and after (green) alignment 
with the cardiac longitudinal axis 
With the final set of ES contour coordinates, a prolate spheroidal mesh was fit to the 
endo- and epicardial data separately in Continuity to obtain two separate mesh layers. 
Continuity utilises a least-squares mesh fitting method to fit the nodes of an 
undeformed mesh to the original data. Then, weights were applied to data points and 
smoothing weights were used. Multiple fittings were performed to eliminate any large 
curvatures estimated by the software. Each final fitting produced a mesh with less than 
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3% root mean square (RMS) error between the mesh and the original data set. A small 
hole was included to eliminate redundant nodes at the apex. The endo- and epicardial 
layers were then incorporated into one 3D mesh model of the LV. Once the 3D mesh 
was obtained, the data was converted to Cartesian coordinates described with a 
combination of tri-cubic and bi-cubic Hermite and Lagrange basis functions. The mesh 
was refined once radially to obtain and endo- and epicardial layers of elements. This 
preliminary model was a coarse mesh composed of 32 hexahedral elements.  
 
Figure 3-3: Patient-specific LV geometry 
To determine the geometric accuracy of the models, the Cartesian coordinates were 
converted into centimetres and the endocardial, epicardial and wall volumes were 
compared to those computed from the original contour data set by Segment. Table 3-1 
displays the respective volumes as well as the error between the MRI LV and model 
volumes. The error between each volume did not exceed 2%. The LV cavity volume at 
ES state (53.41 mL) closely aligns with measured LV cavity volume for healthy human 
hearts (Lorenz et al., 1999).   
Table 3-1: MRI and model volume comparison 
 Epicardial Volume Cavity Volume Wall Volume 
MRI 181.13 53.85 127.28 
Model 182.7 53.41 129.29 
Error 0.87% -0.82% 1.58% 
 
Once the model geometry was verified, fibre angles obtained from human ex vivo 
diffusion tensor magnetic resonance imaging (DTMRI) were applied to the model 
(Rohmer et al., 2007). Fibre angles, applied at each node, varied depending on 
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longitudinal (apex, equator, base) and radial (endocardium, midwall, epicardium) 
location (see Table 3-2 and Figure 3-4 for graphical representation).  
Table 3-2: LV myofibre angles applied to the reconstructed geometry (Rohmer et al., 2007) 
 Basal Equatorial Apical 
Epicardium -30.45° -28.16° -25.88° 
Midwall 9.55° 10.11° 10.67° 
Endocardium 49.55° 48.38° 47.21° 
Constitutive and active stress models were applied and the mesh was refined three 
times radially to produce a final 96 element mesh with six radial layers. Continuity 
automatically interpolated fibre angles at new nodes during radial mesh refinement to 
produce a linear gradient transmurally and longitudinally through the LV wall. Six 
radial layers were strategically chosen to adequately represent the infarct area with 
injected hydrogel in two different distributions. Additional radial layers would have 
greatly increased computation time. As well, fewer el ments are needed to 
appropriately describe the LV when high order basis functions are used. Other cardiac 
and LV models created in Continuity have similarly used coarse meshes with high order 
basis functions (Kortsmit et al., 2012a, Costa et al., 1996, Vetter and McCulloch, 1998).   
 
Figure 3-4: DTMRI fibre angles applied to 96-element LV mesh 
3.2. Constitutive Models 
Passive filling of the LV was described using a transversely isotropic exponential 
function of Lagrangian strains that models the material as nearly incompressible (Liu 
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et al., 1994). The assumption that myocardium is nearly incompressible requires the 
decoupling of the strain energy function into dilatational and deviatoric components: 
 ( = CD #(E 60F9 (3.1) 
in which U is the volumetric contribution (Weiss et al., 1996). The more specific form of 
the strain energy function can be represented by the following: 
 ( = 1201G − 1 +	07HIJ!DKLD − D + 1 (3.2) 
with 
 
3 = 	$4444 # $55677 # 88 # 78 # 879
# $45647 # 74 # 48 # 849 
 
(3.3) 
where C is the stress scaling coefficient; K is the bulk modulus; and J is the determinant 
of the deformation gradient. The second term of the strain energy function W 
represents the penalty function to model the passive myocardium as nearly 
incompressible (Doll and Schweizerhof, 2000). In the expression for Q (Eq. 3.2), bff is 
the fibre strain coefficient; bxx is the cross-fibre strain coefficient; and bfx is the shear 
strain coefficient; Eff is the fibre strain; Ecc is cross-fibre in-plane strain; Ess is the radial 
strain transverse to the fibre; Ecs is the shear strain in the transverse plane; and Efc and 
Efs are shear strain in fibre – cross-fibre and fibre – radial coordinate planes, 
respectively.  
Active myocardium, during sys olic contraction, was modelled as the sum of passive 
stress derived from the strain energy function (Eq. 3.1), and an active fibre directional 
component (T0), which is a function of time (t), peak intracellular calcium 
concentration (Ca0), sarcomere length at which no active tension develops (l0), stress-
free sarcomere length (lR), and maximum isometric tension achieved at the longest 
sarcomere length (Tmax): 
  = 2D0M # 2DM &N 1O PQ(EQ0 R + ST<U, 0 T, K, SI	5= (3.4) 
in which S is the second Piola–Kirchoff stress tensor, p is the hydrostatic pressure, J 
indicates the Jacobian of the deformation gradient tensor, C is the right Cauchy–Green 
deformation tensor, Dev represents the deviatoric projection operator and (E  is the  
isochoric contribution of the strain energy function, W (Wenk et al., 2011a, Weiss et al., 
1996). 
The active fibre directional stress component is defined by a time-varying elastance 
model, which, between peak tension and the end of relaxation, can be reduced to: 
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ST = 12SI	5 0 T0 T + 0 .TV1 − %WX YP U − UTZK![2 + 1 + $ + 1R\]^ (3.5) 
where m and b, the slope and time-intercept, respectively, of the linear relaxation 
duration-sarcomere length relation, are constants (m = 1.0489 s/µm and b = -1.429 s) 
and UT is the time to peak tension (Guccione et al., 1993).  
In addition, the calcium sensitivity, ECa50, dependent on the sarcomere length, is 
formulated as: 
 0 .T =	 0 TI	5
_1"2@6K`[2 + 1 − KT9B − 1 (3.6) 
where B (4.75 µm-1) is a constant that governs the shape of the peak isometric tension-
sarcomere length relation, (Ca0)max is the maximum peak intracellular calcium 
concentration, lR is the stress-free sarcomere length and l0 is the sarcomere length at 
which no tension is developed (Guccione et al., 1993). 
The material constants for active contraction were set to the following values: Ca0 = 
(Ca0)max = 4.35 µmol/ l (Ter Keurs, 1983), l0 = 1.58 µm (Ter Keurs et al., 1980), lR = 1.85 
µm, and Tmax= 135.7 kPa (Guccione et al., 1993). 
Table 3-3: Constitutive model parameters for healthy LV model (Guccione et al., 1993) 
Parameter Variable Value Unit 
Fibre strain coefficient bff 18.5   
Cross-fibre strain 
coefficient 
bxx 3.58   
Shear strain coefficient bfx 1.63   
Stress scaling coefficient C 0.52   
Bulk modulus B 100 kPa 
3.2.1. Boundary Conditions 
For systolic and diastolic simulations, axisymmetric boundary conditions were applied 
at the epicardial basal and apical nodes. Nodal coordinates at the epicardial base as 
well as their circumferential and transmural derivatives were fixed. In this way, 
expansion of the epicardial basal contour was restricted in order to simulate the effects 
of stiff annuli of the valves. At the apex, nodal derivatives in the longitudinal and 
circumferential direction were fixed to prevent unrealistic deformations around the 
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small apical hole (Guccione et al., 1995, Vetter and McCulloch, 2000a). Apical nodes 
were not, however, fixed in space.   
Referring to the schematic diagram in Figure 3-5, the mathematical expressions of 
boundary conditions and their locations are summarised in Table 3-4. 
 
Figure 3-5: The rectangular Cartesian model coordinate system (x1, x2, x3) is co-linear with the long 
axis of the LV. The prolate spheroidal coordinate system (λ, µ, θ) is convenient for modelling 
cardiac geometry. The curvilinear coordinates (ξ1, ξ2, ξ3) are local finite element coordinates. 
Table 3-4: Boundary conditions applied to LV models for diastolic and systolic simulations 
Constraint Location 
a" = 0 Epicardial base 
a Q"Q = 0 Epicardial base and apex 
a Q"Q& = 0 Epicardial base 
a Q"Q = 0 Apex 
a Q
"
QQ = 0 Apex 
a Q
"
QQ& = 0 Epicardial base and apex 
a Q
"
QQ& = 0 Apex 
a Q
"
QQQ& = 0 Apex 
 
In these expressions, i represents one of the spatial coordinates: 1, 2 or 3. Constrained 
nodes are highlighted in Figure 3-6.  
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Figure 3-6: LV model with constrained nodes highlighted in pink 
3.2.2. Building the ESPVR and EDPVR 
Diastole was simulated by applying a pressure to the endocardial surface of the end-
systolic state model. The pressure was increased linearly from 0 – 1.35 kPa (10.1 
mmHg). The stress scaling coefficient (C) of the strain energy function (Eq. 3.1) was 
optimised until the EDV after inflation approximately matched the measured EDV from 
the MRI dataset. Once the EDPVR was obtained, the ESPVR was built by adding active 
contraction to the passive model. Systolic simul tions were performed with a 
prescribed initial LV cavity pressure and volume, using the nodal file from the 
geometry corresponding to the initial pressure obtained from the EDPVR. Active 
contraction was applied and the volume was held constant until a peak pressure was 
reached. Similar simulations with differing initial conditions were run until a peak 
pressure of approximately 13.5 kPa (100 mmHg) and two pressure values bracketing 
the peak value were achieved. The peak pressures were plotted against the 
corresponding volumes to build the ESPVR. The number and size of time steps varied 
for each model in order to achieve convergence in minimal computational time. Python 
scripts were used to run all simulations. For each model, the EDPVR script was 
executed only once but the ESPVR script was run enough times to reach the desired 
peak pressure.  
3.3. Modelling an Infarction 
In the final mesh, an array of 24 elements (6 radial x 2 longitudinal x 2 circumferential) 
in the anterior apical region, were defined as infarction, accounting for 16% of the total 
LV wall volume in the ES state (see Figure 3-7). An infarct covering 20% is critical, 
beyond which, morbidity and mortality drastically increase (Miura and Miki, 2008).  
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A) 
 
B)  
 
Figure 3-7: A) 96 element mesh of entire LV and B) Isolated 24 element mesh of infarct region 
The effects of MI on ventricular pump function were investigated at two time points 
during LV remodelling, acute ischaemia and fibrosis. The stress scaling coefficient and 
infarct geometry were adapted for the infarcted area to mimic the changes in stiffness 
and wall thickness through the remodelling process.  
Due to cell death and degradation of the structural proteins in the infarcted 
myocardium, passive stiffness decreases in the acute infarct stage (Holmes et al., 2005). 
For this post-infarct time point, the infarct stiffness was modelled as 50% of the 
healthy myocardium. As the collagen replaces the necrotic cardiomyocytes and the scar 
forms in the infarct region, the tissue increases in stiffness approximately 10 fold (Sun 
et al., 2009). Table 3-5 shows the exact values used for the stress scaling coefficients at 
each post-infarct time point.  
Table 3-5: Stress scaling coefficients for healthy and infarcted myocardium at acute and fibrotic 
phases 
Model Stress Scaling Coefficient (infarct) - C Stress Scaling Coefficient (healthy) - C 
Healthy n/a 0.52 
Acute 0.26 0.52 
Fibrotic 5.2 0.52 
 
In order to create a thinned infarct wall, an incremental pressure increase was applied 
to the internal and external surfaces of the infarct region in order to thin the wall in the 
isolated region. Nodes surrounding the infarct region were fixed in every direction to 
restrict thinning of the LV wall outside the infarct region. This thinning procedure was 
repeated until the desired infarct wall volume was achieved. Active contraction was 
prohibited in the infarct region in each model by setting the intracellular calcium 
concentration, Ca0 of the active tension model (Equation 3.5), to zero.  
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A) 
 
B) 
 
Figure 3-8: A) Healthy and B) Fibrotic mesh with thinned wall 
3.4. Modelling Hydrogel Injection 
Hydrogel injection was modelled in two ways: A) as bulk and B) layered injection. 
Histological images gathered post-in vivo studies (Dobner et al., 2009, Kadner et al., 
2012) showed that the PEG gel resembles a bolus when injected during the fibrotic 
stage of ventricular remodelling (i.e. C = 5.2) and a multi-layer structure when injected 
during acute ischaemia (i.e. C = 0.26) (Figure 3-9).   
 
Figure 3-9: Histology images of a layered PEG injectate in infarcted rat myocardium at acute infarct 
time point (left) and a bulk distribution obtained when injecting 7 days post-infarction (right). PEG 
gel is shown in purple and cardiomyocytes seen in blue. Scale bare indicates 50 µm (Kadner et al., 
2012). 
For the layered distribution (Figure 3-10 A and C), layers 2 and 5 were modelled as 
hydrogel while 1, 3, 4 and 6 were infarcted myocardium. In the bulk distribution 
(Figure 3-10 B and D), layers 3 and 4 were modelled as hydrogel while 1, 2, 5 and 6 
were infarcted myocardium. Both distributions are shown in Figure 3-10 where the 
red elements represent hydrogel and blue elements represent infarcted myocardium. 
The gel was modelled as a non-contractile (Ca0 = 0 µmol/L), isotropic material (bff = bxx 
= 18.5, bfx = 1.63). The stiffness of the hydrogel was based on mechanical testing of a 
non-degradable polyethylene glycol hydrogel which indicated that the stiffness of the 
gel was 50% of the stiffness of the healthy myocardium [unpublished data].  
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The gel injection was modelled as a wall-thickening in the infarct region. The original 
(healthy) geometry was used to represent the fibrotic (thinned) infarct with hydrogel. 
A new mesh with a thickened infarct region was created to model the acute infarct with 
injected hydrogel. The LV geometry with a thickened infarct was created in a similar 
manner to the thinned fibrotic model discussed previously. However, in this case, 
negative pressures were applied to the internal and external surfaces of the isolated 
infarct region until the desired wall volume was achieved. Again, strict constraints 
were applied to the nodes surrounding the infarct to prevent global thickening of the 
LV wall. The infarct area of the fibrotic model was thinned corresponding to decreases 
in wall volume of approximately 6.825 mL and the acute plus hydrogel model was 
thickened by the same amount. This consistency was maintained in order to model 
each case with approximately the same amount of hydrogel injection. Figure 3-10 
illustrates the geometries of the infarct region at acute (C and D) and fibrotic (A and B) 
time points with both layered (B and D) and bulk (A and C) distributions of hydrogel 
injection.  
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A) B) 
  
C) D) 
  
 
Figure 3-10: Injection scenarios: A) Layered gel injection in acute infarct simulated with hydrogel 
as transmural layers 2 and 5, B)Bulk injection in acute infarct simulated with hydrogel as 
transmural layers 3 and 4, C) Layered gel injection in fibrotic infarct simulated with hydrogel as 
transmural layers 2 and 5, D) Bulk injection in fibrotic infarct simulated with hydrogel as 
transmural layers 3 and 4 
3.5. Data Analysis 
The EDPVR and ESPVR were calculated and plotted to obtain cardiac functional 
parameters such as EF, contractility and EDV, which gave an indication of relative 
cardiac performance of the healthy LV, infarcted LV and infarcted LV with injected 
hydrogel. The calculation of these parameters was described in Section 2.1.3. 
For the healthy model, the Cauchy stress and Green-Lagrangian strain (Eq. 3.7) values 
were computed for the Gaussian points within each individual element according to the 
equations below. 
  = 12 b ∙   + 
(3.7) 
F is the deformation gradient tensor and τ is the stress in the tissue. Stress and strain 
were calculated in the fibre direction and three principal cardiac directions 
(circumferential, longitudinal and radial). The cardiac directional stress and strain 
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values were used to assess the validity of the healthy model. In particular, the averaged 
stress and strain in the endo- and epicardial layers at the basal, mid-ventricle and 
apical locations were examined along with the transmural variation of stress and strain 
through the LV wall. Fibre stress and fibre strain data were obtained for all models. In a 
post-processing Octave script, the stress and strain values at the Gauss points were 
averaged over each element. For calculations of mean infarct, mean BZ and mean LV 
fibre stresses and strains, the stress and strain values were then weighted according to 
the element volume as demonstrated in Eq. 3.8 for the mean LV fibre strain:  
 d,ef = V1LVY1Z,gIg> ] × def^
i
> 	^	 (3.8) 
 
with n = 96 and m = 27 where E11,j is the strain value at Gauss point j, m is the number 
of Gauss points per element, Vi is the volume of element i, and Vklm is the average 
element volume of the entire LV and n the number of elements in the LV. The maximum 
stress and strain values for the infarct region were obtained from the non-weighted 
values. When performing further analysis, i.e. calculating the mean fibre strain in the 
infarct region, any outlying values outside three standard deviations from the mean 
were excluded from calculations of the mean.  
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4. Results 
4.1. Model Verification 
4.1.1. Model Geometry and Cardiac Functional Parameters 
An overview of epicardial, cavity and wall volume for the MRI data and the model of 
the healthy LV is presented in Table 4-1. After fitting a FE mesh to the MRI contour 
data of the healthy LV, the error in cavity and wall volume between MRI and model 
were 0.82% and 1.58%, respectively.  
Table 4-1: LV epicardial, cavity and wall volumes for original MRI data and healthy FE mesh 
 
Epicardial Volume (mL) Cavity Volume (mL) Wall Volume (mL) 
MRI 181.13 53.85 127.28 
Model 182.70 53.41 129.29 
 
Figure 4-1 illustrates the end-diastolic pressure-volume relationship (EDPVR) and the 
end-systolic pressure-volume relationship (ESPVR) determined for the healthy LV 
model. The maximal pressure that can be developed by the ventricle at any given LV 
volume is defined by the ESPVR, which represents the inotropic state of the ventricle. 
Specifically, the slope of the ESPVR represents the contractility of the LV. The predicted 
contractility of the healthy LV was 0.236 kPa/mL.
 
Figure 4-1: Simulated ESPVR and EDPVR for a healthy LV 
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As shown in Table 4-2, the model-predicted EDV is lower than the average human EDV 
and the predicted ESV is greater than the average human ESV. However, the model-
predicted EDV closely matched the EDV calculated from MRI images (111.05 mL).  
Table 4-2: Model-predicted EDV and ESV compared to average human EDV and ESV 
 Predicted Average (Schlosser et al., 2005) 
End-diastolic Volume (mL) 111.65 120 
End-Systolic Volume (mL) 65.60 50 
4.1.2. Stress and Strain 
The transversely isotropic exponential strain energy function used to describe passive 
filling of the LV and the Guccione model for active stress which described contraction 
of the healthy myocardium have previously been compared to in vivo animal data in 
other FE studies and have since been used extensively (Vetter and McCulloch, 2000a, 
Guccione et al., 1995, Costa et al., 2001, Walker et al., 2005). Predicted stress and strain 
values for the healthy model generally agreed with previous studies. For example, fibre 
strain values fell within a similar range compared to those predicted by the Guccione 
FE LV model (Guccione et al., 1995). Therefore, these constitutive and active stress 
models were subsequently used for the case study models.  
4.2. Stress and Strain Predicted for Healthy Ventricle 
For the healthy LV model, stresses and strains predicted in the principal cardiac 
directions (circumferential, longitudinal and radial) and the fibre direction at end-
diastolic and end-systolic time points were assessed for validity. The analysis 
(described in detail in Section 3.5) focussed on 
• the averaged stress and strain in the endo- and epicardial layers at the basal, mid-
ventricle, and apical locations, and 
• the transmural gradients of stress and strain. 
4.2.1. End-diastole 
Shown in Table 4-3, endocardial strains at ED were greater than epicardial strains in 
the fibre, circumferential, longitudinal and radial directions. The greatest stretch 
occurred in the longitudinal direction.  
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Table 4-3: Comparison of ED mean fibre, circumferential, longitudinal and radial strain 
averaged for the base, mid-region and apex of the LV (Endo = endocardium, Epi = 
epicardium) 
 
Fibre Strain Circumferential Strain Longitudinal Strain Radial Strain 
 
Epi Endo Epi Endo Epi Endo Epi Endo 
Base 0.099 0.137 0.112 0.116 0.213 0.353 -0.185 -0.179 
Mid 0.111 0.170 0.105 0.139 0.209 0.186 -0.177 -0.208 
Apex 0.041 0.037 0.034 0.027 0.070 0.026 -0.051 -0.034 
 
The transmural gradient of the strain in the principal directions at the longitudinal 
mid-ventricular level is illustrated in Figure 4-2. The magnitude of circumferential and 
radial strains increased while longitudinal strain decreased slightly from epicardium to 
endocardium.  
 
Figure 4-2: Transmural gradient of ED circumferential, longitudinal and radial strain in the 
mid-ventricular longitudinal location 
The averaged endocardial and epicardial ED stress values showed greater basal stress 
at the endocardial surface than the epicardial surface in all principal cardiac and fibre 
directions, see Table 4-4. At the apex, circumferential and fibre stress were greater at 
the epicardium than the endocardium. In addition, endocardial fibre stress was 
considerably higher than stress in any other direction. Figure 4-3 illustrates the 
transmural variation of circumferential, longitudinal and radial stress from 
endocardium to epicardium. Longitudinal and radial stress increased nearly linearly 
from epicardium to endocardium whereas circumferential stress decreased from 
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epicardium to a minimum in the mid-wall region and increased thereafter to 
endocardium although remaining below the epicardial value.  
Table 4-4: Comparison of ED fibre, circumferential, longitudinal and radial stress averaged 
for the base, mid-region and apex of the LV (Endo = endocardium, Epi = epicardium) 
 Fibre Stress (kPa) 
Circumferential 
Stress (kPa) 
Longitudinal 
Stress (kPa) 
Radial Stress 
(kPa) 
 Epi Endo Epi Endo Epi Endo Epi Endo 
Base 1.508 4.707 0.692 3.958 -0.424 2.944 -0.260 2.781 
Mid 2.707 2.830 1.157 0.989 0.361 0.971 0.323 1.131 
Apex 1.128 0.818 0.066 0.011 0.426 0.324 0.537 0.487 
 
 
Figure 4-3: Transmural gradient of ED circumferential, longitudinal and radial stress in the 
mid-ventricle 
 
4.2.2. End-systole 
ES strain (Table 4-5) was negative in the fibre, circumferential and radial directions 
but positive in the longitudinal direction. Circumferential strain generally decreased 
from the base to apex. Endocardial and midwall circumferential strain was least in the 
mid-ventricle. Longitudinal strain decreased from the basal to apical layer. 
Longitudinal strain at the basal endocardium was greater than in the midwall or 
endocardium. Radial strain increased from base to apex. Figure 4-4 illustrates the 
transmural variation of ES strain in the longitudinal mid-ventricle. Longitudinal and 
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radial strain varied very little from epicardium to endocardium.  However, the 
circumferential strain generally decreased from epicardium to endocardium.  
Table 4-5: Comparison of ES fibre, circumferential, longitudinal and radial strain averaged 
for the base, mid-region and apex of the LV (Endo = endocardium, Epi = epicardium) 
 
Fibre Strain Circumferential Strain Longitudinal Strain Radial Strain 
 
Epi Endo Epi Endo Epi Endo Epi Endo 
Base -0.021 -0.001 -0.021 -0.002 0.073 0.25 -0.158 -0.085 
Mid -0.01 -0.035 -0.006 -0.047 0.038 0.021 -0.14 -0.14 
Apex -0.069 -0.08 -0.022 -0.039 -0.001 -0.012 -0.028 -0.016 
 
 
Figure 4-4: Transmural gradient of ES circumferential, longitudinal and radial strain in the 
mid-ventricle 
ES stresses are listed in Table 4-6. Stress in the fibre and all three principal cardiac 
directions were greater at the endocardium than the epicardium. The magnitude of 
fibre, circumferential, longitudinal and radial stress each decreased from base to apex. 
Circumferential and longitudinal stress decreased from base to apex and radial stress 
increased from base to apex. Stress in all the directions was greatest at the 
endocardium and least at the epicardium. Figure 4-5 shows that circumferential, 
longitudinal and radial stress each increased from epicardium to endocardium in the 
longitudinal mid-ventricle. Longitudinal and radial stress only increased slightly 
through the LV wall. 
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Table 4-6: Comparison of ES fibre, circumferential, longitudinal and radial stress averaged for the 
base, mid-region and apex of the LV (Endo = endocardium, Epi = epicardium) 
 
Fibre Stress (kPa) 
Circumferential  
Stress (kPa) 
Longitudinal 
Stress (kPa) 
Radial Stress (kPa) 
 
Epi Endo Epi Endo Epi Endo Epi Endo 
Base 23.094 47.859 16.670 52.691 2.547 24.338 -14.784 6.840 
Mid 18.498 33.869 17.594 37.557 1.705 7.261 -11.930 -1.788 
Apex 2.278 6.018 1.747 5.720 -2.053 -0.979 -4.122 -1.438 
 
 
Figure 4-5: Transmural gradient of ES circumferential, longitudinal and radial stress in the mid-
ventricle 
4.3. Case Study: Effects of Infarction and Therapeutic Hydrogel 
Injection on Left Ventricular Function and Myocardial 
Mechanics 
4.3.1. Model Geometries 
The cavity and wall volume of the healthy and acute infarct models coincided since the 
same mesh was used for each case. The model for the acutely infarcted LV with injected 
hydrogel, and hence thickened wall in the infarct region, exhibited a decrease in cavity 
volume and an increase in wall volume. The thinned fibrotic infarct LV model resulted 
in a slightly greater cavity volume and a diminished overall wall volume. Since the 
fibrotic infarct with injected hydrogel was represented with the healthy LV geometry, 
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the volumes coincide between these models. The epicardial, cavity and wall volumes of 
each model are presented in Table 4-7. 
Table 4-7: LV epicardial, cavity and wall volumes for various models (mL) (H = healthy, AI = acute 
infarct, FI = fibrotic infarct, LG = layered hydrogel, BG = bulk hydrogel) 
 
Epicardial Volume (mL) Cavity Volume (mL) Wall Volume (mL) 
MRI 181.13 53.85 127.28 
H 182.70 53.41 129.29 
AI 182.70 53.41 129.29 
FI 174.04 55.87 118.17 
AI + LG 187.52 50.06 137.46 
AI + BG 187.52 50.06 137.46 
FI + LG 182.70 53.41 129.29 
FI + BG 182.70 53.41 129.29 
 
The tissue volume, hydrogel volume and total wall volume in the infarct region is 
summarised for all infarcted LV geometries in Table 4-8. The infarct area of the fibrotic 
model was thinned by 6.82 mL and the acute plus hydrogel model was thickened by the 
same amount. This consistency was maintained in order to model each case with 
approximately the same amount of hydrogel injection. However, due large curvatures 
in the LV wall, radial refinement did not result in infarct elements of uniform volume 
and the volume of hydrogel inclusion for the acute cases was greater than for the 
fibrotic cases.  
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Table 4-8: Tissue, hydrogel, and total volumes for LV wall of models for the various infarct 
cases (AI = acute infarct, FI = fibrotic infarct, LG = layered hydrogel, BG = bulk hydrogel) 
 
Tissue Volume in Infarct 
Area (mL) 
Hydrogel Volume 
(mL) 
Total Wall Volume in Infarct 
Area (mL) 
AI 20.58 --- 20.58 
FI 13.76 --- 13.76 
AI + LG 18.35 9.04 27.38 
AI + BG 19.16 8.22 27.38 
FI + LG 13.74 6.85 20.58 
FI + BG 13.79 6.80 20.58 
4.3.2. Cardiac Functional Parameters 
Figure 4-6 represents the EDPVR for all models. Diastole was simulated using the same 
parameters, boundary and loading conditions for each case. Due to the differences in 
the infarct region, each EDPVR displays differences in end-diastolic volume (EDV).  
 
Figure 4-6: EDPVR for healthy and infarcted cases with and without hydrogel injection 
The EDV increased from the healthy (111.65 mL) to the acute infarct case (113.46 mL) 
but decreased in the fibrotic infarct (108.39 mL), illustrated in Figure 4-7. The models 
of infarcted LV with hydrogel injection exhibited lower EDV values than healthy and 
infarct model without hydrogel for both the acute and fibrotic case. While a discernibly 
lower EDV was predicted for the layered gel compared to the bulk gel in the acute 
infarct, the EDV was nearly the same for both gel distributions in the fibrotic infarct. 
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Figure 4-7: End-diastolic LV cavity volumes for healthy, infarcted and infarcted models 
with injected hydrogel 
The ESPVR for each case is shown in Figure 4-8 and the contractility of the LV in each 
case was computed as the slope of the ESPVR curve.   
 
Figure 4-8: End-systolic pressure-volume relationship for each model 
The contractility of the healthy model (0.236 kPa/mL) (Figure 4-9) was reduced in 
both the acute and the fibrotic infarct without gel injectates to 0.195 kPa/mL and 0.202 
kPa/mL for the acute and fibrotic infarct models, respectively. Adding the hydrogel 
material led to a further decrease in contractility of the infarcted LV. This effect was 
more pronounced for layered injectates compared to the bulk injectates.  
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Figure 4-9: Contractility of the LV during systolic phase (calculated as the slope of the ESPVR curve) 
The stroke volume (SV = EDV – ESV) decreased from the healthy case (46.04 mL) to the 
acute and fibrotic cases, 32.37 mL and 35.74 mL, respectively. The SV for each hydrogel 
case were comparable, only varying slightly between 32.33 mL and 32.88 mL. See 
Figure 4-10.  
 
Figure 4-10: Stroke volume for each model 
The ejection fraction (EF) resulting from the active contraction in the healthy case was 
approximately 41.23%, see Figure 4-11. EF decreased for both the acute and fibrotic 
infarct cases, to 28.53% and 32.97%, respectively. Injection of hydrogel, whether 
layered or bulk, into the acute infarct caused a slight improvement in EF infarct 
without hydrogel. However, hydrogel injection into the fibrotic infarct resulted in a 
lower EF.  
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Figure 4-11: Ejection fraction (SV/EDV) for each model 
4.3.3. Stress and Strain Analysis 
A further part of the FE analysis using the developed models was the evaluation of 
stresses and strains during both passive diastolic filling of the LV and active 
contraction as described in Section 3.5. This section presents the Cauchy fibre stress 
and Green-Lagrangian strain values averaged over the infarct and entire LV for each 
model.  
4.3.3.1. End-diastolic Fibre Stress and Fibre Strain 
Figure 4-12(A), illustrates ED fibre stress averaged over the entire LV. The fibre stress 
increased slightly from the healthy to the acute and fibrotic infarct models. The layered 
and bulk hydrogel models exhibited lower mean LV fibre stress than the infarcted 
models without hydrogel. The fibre stress in the fibrotic infarct, shown in Figure 
4-12(B), increased by 190% from the healthy case. The fibrotic model with hydrogel 
included exhibited a lower ED fibre stress in the infarct region. Maximum ED fibre 
stress in the infarct exhibited similar trends to the mean ED infarct fibre stress, seen in 
Figure 4-12(C). Apparent in Figure 4-12(D), mean BZ fibre stress increased slightly in 
the acute infarct but decreased in the fibrotic infarct compared to the healthy model. 
Decreased BZ stress was predicted in both infarct cases with hydrogel injectates 
compared to infarcts without hydrogel.  
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Figure 4-12: A) Mean LV, B) mean infarct, C) maximum infarct and D) mean BZ end-diastolic fibre 
stress (Note different scale for stress in C) 
Evident in Figure 4-13(A), there were only small changes in mean LV ED fibre strain 
between the healthy LV model and the infarcted cases. Infarct models with hydrogel 
injection exhibited slightly lower mean LV ED fibre strains. However, larger differences 
are apparent in the infarct region. As indicated in Figure 4-13(B), mean ED fibre strain 
in the infarct was greater in the acute infarct than the healthy anterior apical region. 
Conversely, infarct fibre strain was lower in the fibrotic infarct than in the same region 
of the healthy case. The infarct cases with hydrogel injection exhibited lower fibre 
strain than their respective infarct models. Again, maximum ED fibre strain seen in 
Figure 4-13(C) in the infarct region similarly showed the same trend of an increase in 
fibre strain in the acute infarct and a decrease in fibre strain in the fibrotic infarct. 
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Mean ED fibre strain in the BZ surrounding the infarct exhibited only minimal variation 
between the healthy, acute infarct and fibrotic infarct models (Figure 4-13(D)). Similar 
to the changes seen in the mean LV ED fire stress, the inclusion of hydrogel in the 
infarct models showed slightly lower ED fibre strain in the BZ compared to the infarct 
models.  
 
Figure 4-13: A) Mean LV, B) mean infarct, C) maximum infarct and D) mean BZ end-diastolic fibre 
strain (Note different scale for strain in C) 
4.3.3.2. End-systolic Fibre Stress and Fibre Strain 
Figure 4-14(A) illustrates a slight increase in overall ES LV fibre stress between the 
healthy model and acute and fibrotic infarct models. Inclusion of hydrogel showed a 
decrease in overall ES LV fibre stress in both the acute and fibrotic infarct models. 
Apparent in Figure 4-14(B), ES mean infarct fibre stress decreased in the acute infarct 
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model by 9.9% and increased in the fibrotic infarct model by 192% compared to the 
healthy case. In both the acute and fibrotic cases, hydrogel injection exhibited lower 
infarct fibre stress values than infarcted models without hydrogel. The maximum 
infarct fibre stress, shown in Figure 4-14(C), was less in the infarct models with 
injected hydrogel compared to the acute and fibrotic infarct models without injectate. 
Figure 4-14(D) illustrates that mean fibre stress in the BZ region was greater in the 
acute and fibrotic infarct models than in the healthy LV model. Infarct models with 
hydrogel injection showed slightly lower ES BZ fibre stress than without hydrogel 
injection at both time points.  
 
Figure 4-14: A) Mean LV, B) mean infarct, C) maximum infarct and D) mean BZ end-systolic fibre 
stress (Note different in scale for stress in C) 
As shown in Figure 4-15(A), mean ES fibre strain for the healthy LV was negative, 
representing a shortening or contraction. In the acute and fibrotic infarct models, the 
fibre strain was positive in the infarct region, associated with fibre extension, shown in 
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Figure 4-15(B). For the acute and fibrotic infarcts with hydrogel, the mean fibre strain 
remained positive but with smaller magnitude in overall LV and infarct region. The 
maximum fibre strain in the infarct (Figure 4-15(C)) displayed a smaller magnitude in 
the acute and fibrotic infarcts with injected hydrogel than the infarct models without 
hydrogel. Seen in Figure 4-15(D), mean ES fibre strain was negative in the BZ region 
for all models except the acute infarct model. The acute and fibrotic infarct models with 
injected hydrogel displayed lower mean ES BZ fibre strain values compared to the 
infarct models without hydrogel.  
 
 
Figure 4-15: A) Mean LV, B) mean infarct, C) maximum infarct and D) mean BZ end-systolic fibre 
strain (Note that A and C are plotted using the same scale for fibre strain and B and C use the same 
scale) 
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5. Discussion 
In this study, the FEM was used to investigate the effect of injecting a polymeric 
biomaterial, polyethylene glycol (PEG), into ischaemic myocardium at two time points 
post-MI. The LV geometry was reconstructed from human cardiac short-axis MRI and 
the infarcts were modelled by changing the LV geometry and material parameters of 
the infarcted region. Seven models were developed representing the following cases: 
healthy, acute infarct, fibrotic infarct, acute infarct with layered hydrogel injection, 
acute infarct with bulk hydrogel injection, fibrotic infarct with layered hydrogel 
injection and fibrotic infarct with bulk hydrogel injection. 
Diastole was simulated by applying a linear pressure increase from 0 – 1.35 kPa to the 
internal surface, inflating the LV passively. Active myocardium was modelled by 
coupling the passive myocardial constitutive model with the Guccione active stress 
model at the cellular level. The predicted stresses and strains from diastolic and 
systolic simulations as well as the cardiac functional parameters were presented in 
Chapter 4. In this chapter, various aspects of the LV model, including the constitutive 
model, model parameters and boundary conditions, are discussed. Thereafter, results 
of the validation of the healthy LV model are examined as well as a comparison of the 
results between the infarcted and infarcted with hydrogel injection models.  
5.1. Development of Finite Element Models 
5.1.1. Geometrical Reconstruction 
High resolution MR images were segmented automatically using the open-source 
software Segment. The software automatically determined epicardial and endocardial 
contours using gradients between pixel values to define each myocardial surface 
contour (Heiberg et al., 2005b). Minor manipulation was necessary in order to 
disregard papillary muscles and valve openings. After segmentation of the endo- and 
epicardial LV contours, the data was shifted to place the origin approximately one-
third of the longitudinal distance from the base. The data was also rotated so that the 
longitudinal axis was aligned approximately through the centre of the LV cavity. This 
was necessary since the original MRI data obtained was not aligned precisely along the 
short-axis of the LV but at a slight angle. This data rotation, performed using Matlab, 
was  subjective as the data was rotated until it appeared to be centred around the z-
axis. Translation and rotation of the data were performed in order to have a more 
accurate fitting of the mesh to the segmented contours in Continuity 6.3 following the 
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method developed by Nielsen et al. (Nielsen et al., 1991, Aguado-Sierra et al., 2011). 
The healthy LV geometry was modelled using prolate spheroidal coordinates. Surface 
geometry was fit to the contour data using least squares optimisation. Although the 
fitting was primarily automated, some manual adjustment of nodes was required in 
order to obtain a smooth mesh. Nodal weights were applied in order to manipulate the 
mesh where necessary. This method of mesh fitting reduces the number of degrees of 
freedom compared with interpolation using Cartesian coordinates. 2D meshes of the 
epicardial and endocardial surfaces were then converted into one 3D mesh described 
with tricubic and bicubic Hermite and Lagrangian basis functions. With less than 2% 
difference in LV wall volume and less than 1% difference in LV cavity volume between 
the model and MRI data, it was concluded that the final mesh accurately represented 
the geometry of the LV. In addition, the method of mesh generation could be easily 
repeated with similar results as the majority of the process was automated with 
minimal user input.  
The model utilises human cardiac fibre angles obtained from DTMRI (Rohmer et al., 
2007). Fibre angles in the human heart ranged from -25.88° to 49.55° transmurally 
from epicardium to endocardium. Helical fibre angles were applied to the endocardial, 
midwall and epicardial nodes. Values also differed depending on the longitudinal 
location: base, equator or apex. One previous computational study of intracardiac 
biomaterial injection therapy (Wenk et al., 2011a), despite modelling an ovine heart, 
used fibre angles from an arrested canine LV (Omens et al., 1991). Fibre angles for the 
canine measured -37°, 23° and 83° for the epicardium, midwall and endocardium, 
respectively. Although variation transmurally is similar, fibre angles differ between 
species and even individuals. Therefore, it was deemed most acceptable to use 
measured DTMRI from a human heart.  
5.1.2. Boundary and Loading Conditions 
The boundary conditions applied to the base of the LV were chosen to emulate the 
stiffening effects of the valves and annuli. At the apex, the boundary conditions were 
chosen to limit non-physiological deformations of the apical hole included in the mesh 
(Guccione et al., 1995, Vetter and McCulloch, 2000b). 
To build the EDPVR, a linear incremental pressure increase was applied to the internal 
surface of the LV to build the LV pressure from 0 – 1.35 kPa. An EDP of 1.35 kPa was 
chosen to mimic the physiology of a healthy human heart (Bovendeerd, 2008). 
Although the linear pressure increase is unphysiologic, the same method was used in 
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numerous studies to obtain reasonably realistic results of cardiac function. Previous 
studies used ED pressures ranging from 0.7 kPa to 2.267 kPa (Walker et al., 2008, 
Kerckhoffs et al., 2007, Wenk et al., 2011b, Kortsmit et al., 2012a). Therefore, the 
method of determining the EDPVR was determined to be a valid method of modelling 
diastolic passive filling.  
To build the ESPVR curve, systolic simulations were run with a prescribed initial LV 
pressure and volume, using the nodal file from the geometry corresponding to the 
initial pressure obtained from the EDPVR. Active contraction was applied and the 
volume was held constant until a peak pressure was reached. Similar simulations with 
differing initial conditions were run until a peak pressure of approximately 13.5 kPa 
(100 mmHg) and two pressure values bracketing the peak value were achieved. The 
peak pressures were plotted against the corresponding volumes to build the ESPVR 
(Kortsmit et al., 2012a). This method provided a simple means of obtaining and 
calculating cardiac functional parameters such as EF, contractility and EDV. In addition, 
ED and ES fibre stress and strain could easily be determined from the final ED and ES 
configurations. External loading on the epicardial surface was assumed to be zero for 
both diastolic and systolic simulations.  
5.1.3. Constitutive and Active Stress Models 
A transversely isotropic exponential strain energy function was used to describe the 
passive component of the LV tissue. Cardiac tissue has also been modelled as an 
orthotropic material (see Section 2.6.4). However, for this model, a transversely 
isotropic material model adequately described the behaviour of the tissue and was 
available within the modelling software Continuity. Constitutive parameters applied to 
the model, including the fibre strain coefficient, cross-fibre strain coefficient and shear 
strain coefficient were based on a canine heart under anaesthesia (Guccione et al., 
1993) since no detailed data on human cardiac stresses and strains in vivo were 
available with which to fit new material model parameters. The parameters used in 
simulations have been tested and validated in previous studies (Guccione and 
McCulloch, 1993).  
The myocardial tissue was modelled as quasi-incompressible with the use of a penalty 
function (Doll and Schweizerhof, 2000). Myocardium is practically incompressible due 
to the water in the tissue and strain energy functions traditionally describe 
incompressible materials. However, bulk myocardium is slightly compressible under 
physiological loads (Yin et al., 1996)and incompressible models are unstable and 
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difficult to converge. A penalty function, however, replaces the constraint of 
incompressibility with a series of unconstrained problems whose solutions ideally 
converge to the same solution as an incompressible model.  
Active myocardium was modelled as the sum of the passive stress component, derived 
from the strain energy function, and the active fibre directional component. The fibre 
directional component was described using a model for active contraction based on the 
peak isometric tension-sarcomere length relation, the maximum peak intracellular 
calcium concentration, the stress-free sarcomere length and the sarcomere length at 
which no tension is developed (Guccione et al., 1993). The active stress model chosen 
provided for ease of manipulation in order to turn on and off contraction in specific 
areas of the myocardium in order to model infarct and hydrogel elements. It has been 
validated with experimental data and used in many previous cardiac computational 
studies (Walker et al., 2005, Wenk et al., 2011b). 
5.1.4. Modelling an Infarction and Hydrogel 
The LV was modelled at two time points after infarction: acute (within seconds-
minutes of infarction) and fibrotic (7 days post-infarction). In both models, 24 
elements in the anterior apical region of the LV model were defined as infarction. The 
infarct was transmural and accounted for 16% of the total LV wall volume at the initial 
state geometry. The acute infarct was only modelled as a reduction in stiffness within 
the infarct area (CAI = ½ CH) and the geometry was left unaltered. The stiffness of the 
acute infarct was chosen based on previous similar studies (Kortsmit et al., 2012a) as 
well as the knowledge that structural proteins begin to degrade immediately after 
infarction, causing a decrease in stiffness (Holmes et al., 2005). The infarcted LV at the 
fibrotic time point was modelled as a 10 fold stiffness increase in the infarct region due 
to the scar formation in the infarct region (Sun et al., 2009). In addition, the fibrotic 
infarct was modelled with wall thinning. In both the acute and fibrotic infarcts, the 
fibre angles were set to 0° and the material was assigned isotropic material properties 
with equal stiffness in the fibre and cross-fibre directions (bff = bxx = 18.5, bfx = 1.63) 
(Gupta et al., 1994).  
The hydrogel was modelled as two different distributions within the myocardium: 
layered and bulk. The two distributions were chosen based on histological images of 
injected PEG hydrogel into infarcted rat myocardium at the acute and fibrotic time 
points (Kadner et al., 2012). Injected at acute ischaemia, the gel stratified into layers 
within the myocardium. Whereas when injected after the scar tissue had formed, the 
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gel appeared as a bolus of gel within the centre of the myocardium. Therefore, these 
two distributions were compared to determine the mechanical effect of different gel 
distributions. New LV model geometries were developed to incorporate wall 
thickening due to simulated hydrogel injection. Previous FE studies investigating the 
inclusion of biomaterial injection modelled the infarct region as homogenous (i.e. with 
no distinction between infarcted myocardium and hydrogel) (Wall et al., 2006, Wenk et 
al., 2011b). Although the two modelled distributions used in this study are quite 
simple, it is a small step toward modelling a realistic distribution of gel within infarcted 
myocardium.   
The hydrogel was also modelled using the transversely isotropic exponential strain 
energy function. Based on unpublished experimental data, the hydrogel was modelled 
with half the stiffness of healthy myocardium. Without more experimental data on the 
PEG material, a more adequate material model could not be applied. 
5.2. Validation of Finite Element Models 
The constitutive and active stress models used in this FE analysis were previously 
validated with experimental data (Guccione and McCulloch, 1993, Guccione et al., 
1993). However, the healthy LV FE model was further validated by comparing the fibre 
strain at ED and ES time points in the cardiac cycle to values from literature. The mean 
LV fibre strain at ED showed little variation transmurally. The fibre strains were, 
however, smaller at the apex due to the boundary conditions imposed in the model. 
Similar to ED fibre strains measured experimentally in rabbit hearts, modelled mean 
ED LV fibre strain was 0.109 (Omens et al., 1991).  
The model predicted a mean ED LV fibre stress of 2.69 kPa. This value was compared 
with a similar model using the same transversely isotropic exponential strain energy 
function to describe passive filling which predicted an mean ED LV fibre stress of 2.91 
kPa (Vetter and McCulloch, 2000a). The small difference could be due to the difference 
in stress scaling coefficient used in each constitutive model.  
At ES, experimental fibre strains were higher than those predicted by the model, by 
almost a factor of five. The reason for this discrepancy is probably due to the fact that 
the unloaded state was used as the reference state to determine strain values at ES 
rather than the ED state.  The unloaded geometry differs considerably from the ED 
geometry; therefore ES strain values are not representative of physiological strains. 
However, they are deemed acceptable to use for model comparison in this study. 
Calculated ES fibre stresses, however, are in close agreement with predicted fibre 
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stresses found in other studies using the same active stress model (Guccione et al., 
1995, Wenk et al., 2011b). Disregarding the small stress values around the apical hole 
due to imposed boundary conditions, mean predicted ES fibre stress in the healthy LV 
model was 28.2 kPa compared to 29.4 predicted by Wenk et al. (Wenk et al., 2011b).  
The ED and ES volumes predicted by the model are smaller than normal physiological 
measurements. However, they are in agreement with the patient MRI. With this 
information, the model was deemed sufficiently accurate for relative comparison of 
fibre stress and strains between the healthy LV, infarcted LV and infarcted LV with 
hydrogel layer models.  
5.3. Comparison of Healthy, Infarcted and Infarcted with Hydrogel 
LV Models 
5.3.1. Cardiac Functional Parameters 
The EDV increased from the healthy (111.65 mL) to the acute infarct case (113.46 mL) 
due to the decrease in stiffness in the infarct region. The decrease in stiffness allowed 
the infarct region to distend greater than normal during diastolic filling, increasing the 
overall EDV. Similarly, the fibrotic infarct, ten times stiffer than the healthy tissue, 
reduced expansion of the myocardium in the infarct region, causing a decrease in EDV 
(108.39 mL) from the healthy case. Hydrogel layers were incorporated into the acute 
and fibrotic infarct models and were modelled as a substantial increase in infarct wall 
thickness associated with the volume of the hydrogel. This increase in thickness caused 
a large reduction in EDV in both the acute infarct (6.9% and 6.1% reduction for layered 
and bulk gel, respectively) and fibrotic infarct (2.5% reduction for both layered and 
bulk gel). There are multiple reasons for the reduction in EDV. Firstly, the increased 
wall thickness resulted in a smaller initial cavity volume (50.06 mL) compared to the 
healthy case (53.41 mL) since the thickness was increased by manipulating both the 
endocardial and epicardial surfaces. Secondly, the models with simulated hydrogel 
injection and thicker wall in the infarct region resulted in a significant decrease in 
strain or tissue stretching in the infarct region, leading to a reduction in EDV for both 
the acute and fibrotic cases with hydrogel injection, compared to the infarct cases 
without hydrogel injectate. 
From the ESPVR for each model, the contractility was determined for each case. The 
contractility decreased from the healthy (0.236 kPa/mL) to the acute infarct (0.195 
kPa/mL) and fibrotic infarct (0.202 kPa/mL) cases. The decrease in contractility is 
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ascribed to the passive behaviour of the infarct area. In the healthy LV model, all areas 
of the myocardium actively contract whereas the infarct area in both the acute and 
fibrotic infarct models only behaves passively. Therefore, contractility of the overall LV 
decreased with incorporation of an infarct. Inclusion of the hydrogel layers caused an 
additional decrease in the contractility. Hydrogel layers, like the infarcted tissue, are 
also non-contractile. Therefore, addition of passive material will not improve the 
contractility of the overall LV. The layered gel caused a greater decrease in contractility 
(0.178 kPa/mL and 0.181 kPa/mL for acute and fibrotic models, respectively) than the 
bulk gel injection (0.184 kPa/mL and 0.200 kPa/mL for acute and fibrotic models, 
respectively).  
EF (=SV/EDV) for the healthy LV model was 41.23%, well below the normal EF for an 
average human (Schlosser et al., 2005) and below the EF measured from MRI LV 
volumes (52.3%). The discrepancy between modelled and physiologic EF is due to the 
fact that the active model parameters are based on a canine under anaesthesia which 
lowers the contractility of the LV (Guccione and McCulloch, 1993). Therefore, the lower 
EF, although not physiologically representative for humans, is admissible. Both infarct 
models exhibited a reduction in EF to 28.53% and 32.97% for the acute and fibrotic 
infarct cases, respectively. This was expected due to the implementation of the non-
contractile infarct region, reducing the efficiency of LV contraction. The addition of 
hydrogel layers into the acute infarct model caused a slight increase in EF to 30.56% 
(change: 7.11%) and 30.85% (change: 8.12%) for the layered and bulk gel model, 
respectively. Conversely, the inclusion of layered and bulk hydrogel in the fibrotic 
infarct model caused a decrease in EF to 30.76% (change: -6.71%) and 30.71% 
(change: -6.88%), respectively.  The decrease in EDV due to simulated hydrogel 
injection alone, previously discussed above, would cause an increase in EF, which can 
explain the change in the EF in the acute model due to hydrogel injection. Since a 
decrease in EF was observed in the fibrotic model due to hydrogel inclusion, the 
change may be explained by a reduction EDV as well as in SV. The stroke volume 
decreased from 35.74 mL in the fibrotic model to 32.49 mL (change: -9.09%) and 32.44 
mL (change: -9.24%) for the layered and bulk hydrogel injection models, respectively. 
The reduction in stroke volume can be explained by the simultaneous decrease in 
contractility with the inclusion of hydrogel discussed previously.   
5.3.2. Stress and Strain Comparison 
The Cauchy stress tensor was used to compare stresses of each model since it 
expresses the true stress of the model. Cauchy stress is a measure of the force acting on 
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an element of area in the deformed configuration. The Green-Lagrangian strain tensor 
was used to compare strain between each model since large deformations occur 
between the undeformed and deformed cases. Physiologically, these strains can be as 
large as 30% (Bovendeerd, 2008). Large strain theory, also known as finite strain 
theory, deals with deformations in which both rotations and strains are arbitrarily 
large, invalidating the assumptions inherent in infinitesimal strain theory. Therefore, 
the Green-Lagrangian strain tensor which describes strain for large deformations was 
used to compare ED and ES strain from each model.  
5.3.2.1. End-diastolic Stress 
ED fibre stress averaged over the entire LV increased only slightly in the acute and 
fibrotic models compared to the healthy. Looking more closely at the mean fibre stress 
in the infarct region only, the acute infarct caused a slight decrease in mean fibre stress 
whereas the mean ED infarct fibre stress in the fibrotic infarct more than doubled. The 
significant increase in fibre stress within the fibrotic infarct is primarily due to the 
decrease in infarct wall thickness. The effect of the wall thickness on ED fibre stress can 
be explained by the equation for circumferential stress in a thick-walled cylinder with 
an applied internal pressure.  
 no = 
 pq
 # p
pq  p (5.1) 
Where Pi is the applied internal pressure; rO is the radius to the outer surface; and ri is 
the radius to the inner surface. If the radius to the inner surface and the applied 
internal pressure remain the same while the outer radius is reduced, the stress will 
increase. In this way, the thick-wall cylinder can explain the increase in stress in the 
thinned fibrotic infarct model.  
The stress is also dependent on the stiffness of the material. A material with greater 
stiffness will exhibit greater stress and a less stiff material will have lower stress. 
Therefore, if the strain remains constant and the stiffness increases, stress will also 
increase. Likewise, if the stiffness decreases, as was the case for the acute infarct, the 
stress decreases. The mean ED infarct fibre stress in the acute infarct model decreased 
by 5.9% from the healthy LV model. Conversely, the mean infarct fibre stress in the 
fibrotic infarct model increased drastically by 189.5%. Changes in material properties 
of the infarct region also affected the stress in the BZ region surrounding the infarct. BZ 
fibre stress increased a minimal amount in the acute infarct model and decreased 
slightly in the fibrotic infarct model. An increase in infarct tissue stiffness, therefore, 
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caused a reduction in fibre stress in adjacent tissue. Likewise, a decrease in tissue 
stiffness in the acute infarct model caused an increase in fibre stress in the BZ. These 
changes are due to the fact that infarcted tissue affects tissue deformation in the 
adjacent BZ.  
Addition of hydrogel layers caused a decrease in ED fibre stress averaged over the 
entire LV due to the increase in infarct wall thickness. Mean ED LV fibre stress in the 
acute infarct model decreased by 12.5% and 11.1% for the layered and bulk hydrogel 
injections, respectively. Similarly, mean LV fibre stress in the fibrotic infarct model 
decreased by 13.6% with a layered gel distribution and 14.2% with a bulk gel 
distribution. Reductions in fibre stress were much more pronounced in the infarct 
region where hydrogel injection caused a 65.3% and 58.5% decrease in infarct fibre 
stress in the acute infarct model for the layered and bulk hydrogel, respectively. In the 
fibrotic model, hydrogel injection had a somewhat smaller effect, reducing fibre stress 
in the infarct region by 38.7% and 35.6% for the layered and bulk gel distributions, 
respectively. The mean fibre stress in the BZ region for the acute infarct model was 
reduced by 6.8% and 4.2% for the layered and bulk gel distributions, respectively. 
Within the fibrotic model, the layered and bulk gel injection reduced fibre stress by 
3.2% and 3.4% in the BZ region, respectively. The fibre stress in the infarct and BZ was 
affected less by hydrogel injection in the fibrotic infarct model than the acute infarct 
model since the prominent property of the fibrotic infarct was the stiffness, being 10 
times that of the healthy tissue and 20 times that of the hydrogel for the fibrotic infarct 
whereas the acute infarct stiffness was half of that of healthy tissue and equal to the 
stiffness of the hydrogel. Therefore, in the acute model, the increase in thickness was 
the prominent factor affecting ED fibre stresses.  
5.3.2.2. End-diastolic Strain 
Mean ED LV fibre strain decreased slightly by 0.9% from the healthy to the acute 
infarct model. The mean ED LV fibre strain decreased by 12.3% from the fibrotic 
infarct model compared to the healthy LV model due to the increase in infarct stiffness. 
In the infarct region, the mean ED fibre strain increased by 27.2% in the acute infarct 
model and decreased by 58.8% in the fibrotic infarct model compared to the healthy 
case. The mean ED BZ fibre strain increased slightly by 1.4% compared to the healthy 
case due to the acute infarct and decreased by 3.7% with inclusion of the fibrotic 
infarct. ED fibre strain is only a result of passive stretching due to the internally applied 
pressure. Despite the material changes in the infarct region, the effect on passive strain 
in the BZ was not great.  
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The addition of hydrogel into the acute infarct model caused a decrease in mean LV, 
infarct and BZ fibre strain. As previously discussed in relation to EDV, an increase in 
wall thickness will cause in a decrease in fibre strain. Therefore, addition of hydrogel 
into the fibrotic infarct model resulted in a decrease in ED fibre strain in the LV, infarct 
and BZ regions. Although the magnitude of fibre strain reduction due to hydrogel was 
much less in the fibrotic infarct model than in the acute infarct model, the relative 
reduction was similar for both cases. The acute infarct fibre strain decreased by 11.2% 
and 10.0% for the layered and bulk gel injections, respectively, while the hydrogel 
injection reduced the fibrotic infarct fibre strain by 10.3% with a layered distribution 
and 16.5% with a bulk gel distribution. It is interesting to observe that for the acute 
infarct, the layered gel distribution has a slightly more pronounced effect in reduction 
of the ED fibre strain compared to the bulk distribution of the gel while the opposite is 
the case for the fibrotic infarct case.  
Addition of hydrogel decreased mean ED BZ fibre strain by 8.4% and 7.2% for the 
layered and bulk distributions, respectively, in the acute infarct model and by 6.8% and 
7.6%, respectively, in the fibrotic model. Similar to the observation for the fibre strain 
in the infarct region, the layered gel distribution elicited a larger reduction in BZ strain 
in the acute infarct model. In the fibrotic infarct model, the bulk gel distribution had a 
larger impact on ED fibre strain. The difference in the effect of the layered and bulk gel 
distributions on ED strain should be investigated further.          
5.3.2.3. End-systolic Stress 
Mean LV ES fibre stress increased by 17.5% in the acute case and 29.3% in the fibrotic 
infarct case compared to the healthy LV model. The acute infarct caused a small 
decrease in mean ES infarct fibre stress (10.0%) while the stiff fibrotic infarct caused 
an immense increase in ES infarct fibre stress (189.5%). During systole, stress is a 
combination of the passive stress and the stress due to active contraction of the 
myocardial fibres. Since both the acute and fibrotic infarcts were non-contractile, the 
stress in the infarct area was solely due to the passive component. Therefore, the 
decrease in infarct stiffness in the acute model caused the decrease in mean ES infarct 
fibre stress. Likewise, the 10-fold increase in tissue stiffness as well as the wall 
thinning applied to the fibrotic infarct model caused the increase in mean infarct fibre 
stress at ES. The BZ fibre stress increased by 45.3% and 34.9% for the acute and 
fibrotic infarct models, respectively, compared to the healthy case.  
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Each ESPVR was developed by simulating active contraction until an ES pressure of 
13.5 kPa was reached. Therefore, in order to achieve the same pressure with an area of 
infarcted, i.e. non-contractile, myocardium, the healthy tissue must contract more in 
order to achieve the same pressure and potentially also account for passive stretching 
if the infarct region in this process. This explains the increase in mean LV and BZ fibre 
stress at ES.  
The addition of hydrogel lowered the ES fibre stress in the infarct and BZ regions. In 
the acute infarct model, a layered hydrogel distribution caused a 74.3% reduction in ES 
infarct fibre stress while the bulk hydrogel distribution caused a 66.0% reduction. 
Hydrogel inclusion in the fibrotic infarct model caused a 59.7% and 60.6% reduction in 
ES infarct fibre stress with the layered and bulk gel distributions, respectively. 
According to the same principle as discussed above, an increase in infarct wall 
thickness due to the hydrogel increases the cross-sectional area over which the force is 
applied. This thickening led to a reduction in infarct fibre stress at ES.  
The impact of hydrogel inclusion was somewhat smaller in the BZ region. In the acute 
infarct model, the layered gel injection reduced ES BZ fibre stress by 9.8% and the bulk 
gel by 8.0%. Layered and bulk gel included in the fibrotic infarct model reduced ES BZ 
fibre stress by 8.5% and 8.4%, respectively.  
5.3.2.4. End-systolic Strain 
ES fibre strain in the healthy LV model was negative since myocardium was 
contracting. However, the acute and fibrotic infarcts, comprising 16% of the LV wall 
volume, were non-contractile and therefore, underwent passive stretching, i.e. positive 
strain, during systolic contraction. The infarct fibre strain increased so drastically that 
it caused the fibre strain averaged over the entire LV to become positive in the acute 
and fibrotic models. Compared to the healthy LV, the mean ES LV fibre strain increased 
by 183.7% and 135.1% in the acute and fibrotic infarct model, respectively. The 
increases in fibre strain were even more prominent when considering the infarct 
region only:388.3% for the acute infarct case and 280.2% for the fibrotic infarct case. 
The acute infarct had a greater effect on the ES fibre strain since it is not only non-
contractile, but also less stiff than the healthy myocardium. Therefore, the less stiff 
material will undergo greater distension and exhibit larger strains. Similarly, the stiffer 
fibrotic infarct will inhibit stretching and reduce strain. However, although the stiffness 
of the fibrotic infarct increased 10-fold compared to the healthy tissue, the infarct area 
was non-contractile, which led to positive strain although smaller than in the acute 
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infarct case. The mean fibre strain in the BZ also increased as a result of the non-
contractile infarct region. The acute infarct caused the mean BZ fibre strain to increase 
by 107.0% and the fibrotic infarct exhibited an 99.3% increase. Although less than the 
changes in fibre strain in the infarct region, these increases are not negligible. The BZ 
tissue remains fully contractile but appears to be inhibited by the adjacent non-
contractile tissue.  
The inclusion of hydrogel layers in the acute infarct model lowered mean fibre strain in 
the LV, infarct region and BZ. The mean LV fibre strain was reduced by 9.4% and 6.4% 
for the layered and bulk gel distributions, respectively. Hydrogel layers had an even 
greater effect in reducing ES mean infarct fibre strains (26.5% and 28.5% for the 
layered and bulk distributions, respectively). Addition of hydrogel layers reduced ES 
fibre strain in the BZ region in both the acute and fibrotic infarct models. Although 
these changes are extremely small in the acute model, the mean ES strain in BZ area 
changed from a positive value (i.e. stretching) to a negative value associated with active 
contraction. The ES mean BZ fibre strain in the fibrotic infarct reduced drastically, 
indicating better overall contraction in the BZ region with inclusion of hydrogel into 
the infarct region. The reduction in fibre strain in each region is due to the increased 
thickness of the infarct region. As previously discussed, the increase in cross-sectional 
area over which a force is applied will reduce the resulting strain. Therefore, increasing 
the wall thickness in the infarct area caused a slight reduction in fibre strain in the LV, 
infarct and BZ regions.  
In the fibrotic model, mean ES LV fibre strain decreased by 71.8% and 43.9% with the 
layered and bulk gel distributions, respectively. The inclusion of hydrogel layers had 
opposite similar effect on mean ES fibre strain in the infarct region alone. Layered and 
bulk gel caused infarct fibre strain to decrease by 35.1% and 36.0%, respectively, 
compared to the fibrotic infarct without hydrogel injection. In the BZ region, both 
layered and bulk gel distributions altered the mean BZ fibre strain from 0.0 in the 
fibrotic infarct without hydrogel to -0.017, improving the contractility of the BZ region.  
5.3.3. Comparison of Hydrogel Injection Results to Literature 
Similar reductions in ED and ES fibre stress were observed in previous computational 
studies on post-MI hydrogel injection. Wenk et al. (2011) observed a 51.2% and 92.8% 
decrease in fibre stress in the infarct region at the ED and ES time points, respectively. 
No results in BZ fibre stress were given. EF increased from 35% to 53% due to the 
increased infarct wall thickness and subsequent reduction in LV dilation. Similarly, 
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injection of hydrogel into the BZ caused a reduction in ES LV fibre stress as well as a 
slight improvement in EF (Wall et al., 2006). In a third study, inclusion of hydrogel 
caused a 25% and 3% decrease in mean ED LV fibre stress for the acute and fibrotic 
infarct models, respectively. Similarly, hydrogel layers in an acute infarct model caused 
a 29% reduction in ES LV fibre stress and hydrogel layers in a fibrotic infarct caused a 
2.1% decrease in ES LV fibre stress (Kortsmit et al., 2012a). This Masters research 
reproduced the results seen in previous computational studies of hydrogel injection 
therapy but also provided further insight into of the effect of the in situin situ 
distribution of the therapeutic injectate, dependent on time of injection, on cardiac 
mechanics.    
5.4. Significance 
There are six general ways in which an infarct can inhibit ventricular pump 
function(Holmes et al., 2005). An infarct may rupture if the stresses in the infarct 
region become too high. Significantly elevated myofibre stress in the infarct region was 
shown in this FE study as a result of the fibrotic infarct. The inclusion of hydrogel into 
the fibrotic infarct model elicited a 35% and 36% decrease in mean infarct fibre stress 
for the layered and bulk injections, respectively. This reduction in ES infarct fibre 
stress could potentially limit the chance of infarct rupture during healing post-MI.  
Secondly, infarct stretching wastes energy generated by healthy myocardium, reducing 
systolic pump function dramatically (Holmes et al., 2005). At ES, the FE model showed 
that infarct fibre strain is positive, indicating stretching, whereas the healthy tissue 
exhibits negative strain, signifying that the tissue is actively contracting. Both acute and 
fibrotic infarcts showed infarct stretching at ES, thereby reducing systolic pump 
function. When hydrogel layers were added to each infarct model, infarct fibre strain 
was reduced. Although infarct stretching was not inhibited entirely, the reduction in 
infarct fibre stretching may recover some systolic functionality of the LV, thereby 
slowing the progression towards HF.  
A stiff infarct can limit diastolic function of the remaining healthy myocardium (Holmes 
et al., 2005). In this study, the fibrotic infarct was modelled as ten times the stiffness of 
the healthy myocardium. At ED, the fibrotic infarct reduced overall mean LV fibre 
strain by 12.3%. This reduction in global LV ED fibre strain is an indication of impaired 
diastolic function. The addition of hydrogel, however, continues to reduce diastolic 
function by additionally limiting mean LV fibre strain. Therefore, addition of hydrogel 
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may not provide a benefit in preserving diastolic function during later stages of infarct 
healing after the stiff scar has formed.  
Infarct expansion and cavity dilation increase wall stress throughout the LV. Neither of 
these was addressed in this study as there was no induced cavity dilation and the 
infarct was assumed to be the same size at both the acute ischaemic and fibrotic time 
point. However, the influence of cavity dilation on the therapeutic effect of the 
injectates was investigated in a related study (Kortsmit et al., 2012b). 
Coupling to the infarct may limit deformation of adjacent myocardium in the BZ 
(Holmes et al., 2005). This effect was clearly shown in the results from this FE study. 
Both mean BZ fibre stress and fibre strain at ES increased as a result of the acute and 
fibrotic infarcts. ES fibre strain values changed from negative (contractile shortening) 
to positive (non-contractile extension) in the acute case. Therefore, tethering to the 
infarct had a significant effect on the deformation of the adjacent myocardium, 
preventing normal contraction. With the inclusion of hydrogel in the infarct region, the 
ES fibre strain decreased in the acute model from positive (non-contractile) to negative 
(contractile), signifying that the adjacent BZ tissue regained some functionality. ES 
fibre strain in the fibrotic infarct also became more negative with inclusion of hydrogel. 
ES fibre stress in the BZ decreased by 8-10% depending on the distribution of gel and 
the phase of the infarct, acute or fibr tic. Although the fibre stresses and strains did not 
return to normal levels seen in the healthy model, the reductions signify that hydrogel 
injection could help to preserve function of healthy adjacent myocardium.  
And finally, the infarct leads to volume-overload ventricular hypertrophy and 
remodelling of healthy tissue (Holmes et al., 2005). Post-MI, stress and strain the non-
infarcted myocardium are largely determined by the material properties of the infarct. 
This study showed slight changes in ED fibre stress and strain averaged over the entire 
LV due to the acute and fibrotic infarcts. However, greater differences were seen at ES 
where mean LV fibre stress increased by 17.5% and 29.3% in the acute and fibrotic 
infarcts, respectively. Similarly, mean LV fibre strain at ES increased by 183.7% in the 
acute infarct and 135.1% in the fibrotic infarct. Therefore, the material changes and 
passive behaviour of the infarcted tissue had a global effect on the fibre stress and fibre 
strain in the entire LV. Simulated injection of hydrogel reduced mean LV fibre stress 
and fibre strain at both the ED and ES time points by varying degrees depending on 
distribution and the time point of injection. Global reduction of fibre stress and fibre 
strain, through optimal biomaterial injection, could then prevent volume-overload 
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hypertrophy and remodelling of healthy myocardium. To verify this, further analysis 
should be done on the fibre stress and strain in only the remote myocardium.  
5.5. Limitations and Recommendations 
One limitation of the model is that it represents a human LV and does not account for 
the effects of the RV or either atria on the mechanics of the LV. The RV and LV act as 
two pumps in series which are mechanically coupled by the lungs. Since they are 
aligned in series, a perturbation in the mechanical events of one ventricle will influence 
the behaviour of the other. The septum between the ventricles and the thin 
pericardium surrounding the heart further promote the mechanical interplay (Fogel et 
al., 1995). Although the LV wall is much thicker and generates higher ES pressures, the 
RV can affect LV pressure generation (Santamore et al., 1988). In addition, omitting the 
RV can allow greater distension of the LV septal wall. A biventricular model would 
produce more accurate results since it would take into account the mechanical 
interactions between the right and left ventricles. Despite the interventricular 
interaction, many cardiac computational studies have previously been carried out 
modelling only the LV (Wall et al., 2006, Wenk et al., 2009, Wenk et al., 2010, Wenk et 
al., 2011a, Guccione et al., 1995). And more specifically, the only prior computational 
studies investigating the effect of biomaterial injection into infarcted myocardium also 
did not include the RV. Disregarding the RV simplifies the FE model, reducing the 
number of elements and consequently, the computational time.  
The hydrogel was modelled as several uniform thin layers and one single bulk layer, 
respectively, within th  infarcted myocardium in an attempt to represent in vivo 
observations, as described in Section 3.4. Figure 3-9shows histology images of layered 
and bulk in situ distributions of polyethylene glycol (PEG) hydrogel injectates in 
infarcted rat myocardium (Kadner et al., 2012). It is apparent that both modelled 
distributions fall short of representing the true geometry of the injected biomaterial. 
The coarseness of the mesh prevented modelling the hydrogel injection with more 
detail. A very fine mesh would have allowed more precise geometrical modelling of the 
injection, which could lead to a more accurate solution, but would have increased 
computational time. Nevertheless, the discrete representation of the injectate was an 
initial step towards the in situ distribution of the injectates compared to previous 
studies in which the presence of biomaterial in the infarcted myocardium was 
described through local thickening and adjustment of the material properties in the 
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infarct region while geometrical features of the injectate were not included (Wenk et 
al., 2011b, Wall et al., 2006).  
The coarse mesh also limited the specificity in element-based calculation of stress and 
strain in the border zone region of the LV. The border zone is typically defined as the 
region immediately adjacent to the infarcted myocardium. However, due to the size of 
the elements, the border zone region in the calculations takes up approximately 32% of 
the LV wall volume whereas the infarct area only takes up 16% of the wall volume. The 
coarseness of the mesh results in a gross overestimation of the BZ region. A more 
refined mesh could be used to calculate stresses and strains in the BZ region, although 
numerical problems were encountered in this study in attempts to use finer meshes. 
An alternative option may be to determine stress and strain values at selected gauss 
points of elements surrounding the infarct region rather than the entire elements.  
The geometry of the fibrotic infarct model was created by inducing wall thinning 
observed in situ. In a similar manner, the geometry of the LV models with injected 
hydrogel was created by inducing wall thickening. Amounts of wall thinning and wall 
thickening were applied with a priori information on infarcted hearts and volumes of 
injectate used in post-MI hydrogel therapy. However, LV dilation, most prominent in 
later stages of LV remodelling was not incorporated into the fibrotic infarct model. 
Therefore, the initial LV cavity volume in the fibrotic infarct model was less than what 
would be observed in vivo. A more accurate means of modelling the LV geometry for 
the infarcted and treated cases would be to use MRI of an infarcted heart and an 
infarcted heart with injected hydrogel. Since hydrogel injection is not yet an accepted 
therapy for post-MI treatment in humans, it is impossible to obtain imaging data of a 
treated and non-treated human infarcted heart. However, with recently developed in-
house small animal MRI, the rat model may potentially be used to obtain cardiac MRI 
and create FE models with a more accurate geometry representing the infarcted LV 
and infarcted LV with injected hydrogel.  
Another limitation of the present FE models is that the residual stresses in the cardiac 
wall are not accounted for. Although the LV is continually loaded in vivo, a starting 
mesh of the geometric “unloaded” state is ideal for simulating diastolic filling and 
systolic contraction in order to approximate accurate stresses and strains at any point 
in the cardiac cycle. While employing an unloaded configuration of the heart may be 
desirable, previous researchers have used the ES (Walker et al., 2005) or mid-diastolic 
(Sermesant and Razavi, 2010) configuration as the reference geometry since the 
ventricular volumes are closer to the expected unloaded diastolic volume.  This model 
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was created using a near ES configuration as the reference geometry to approximate 
the LV at after isovolumetric relaxation, as shown in Figure 5-1. 
 
Figure 5-1: Approximate unloaded state of the LV on the PV loop 
However, it will be useful in future research to determine the unloaded or reference 
geometric state of the LV in order to account for residual stresses in the model. One 
method for determining the unloaded geometry in cardiac ventricles is based on the 
multiplicative decomposition of the deformation gradient tensor. The objective of the 
iterative estimation scheme is to find the unloaded reference geometry that minimises 
the difference between the measured end-diastolic geometry and the computed 
geometry when the unloaded model  is inflated to the measured end-diastolic 
pressures (Aguado-Sierra et al., 2011). Another method of determining the unloaded 
geometric state of the LV and the residual stresses is being developed by collaborators 
at UCT and may be implemented in future cardiac models. In this research, the results 
are accurate enough as they provide a basis for comparison between healthy, infarcted 
and treated cases.  
The active stress model incorporated into the LV model and the associated parameters 
were originally used to describe active mechanics of a canine heart. Although canine 
and human LV mechanics are extremely similar, minute differences may affect the final 
calculation of stresses and strains. Ideally, mechanical testing should be performed and 
parameters should be fit to experimental data of human myocardium in order to use a 
more accurate model for the active stress.  
The EDPVR was generated by applying an incremental pressure increase on the 
endocardial surface of the LV until the EDP of 1.35 kPa was achieved. The ESPVR was 
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built by allowing the pressure to increase due to the active contraction model until the 
desired ESP was achieved. The LV was not coupled to a closed-loop circulation model. 
Ideally, a suitable circulation model, such as a Windkessel model, should be applied to 
account for pre- and after-load effects of the circulatory system. In a model coupling 
circulation to LV mechanics, end-diastolic pressure also becomes an output of the 
model and no longer needs to be prescribed. By coupling to a closed-loop circulation, 
the introduction of an ischaemic region would shift the PV loop to the right, increasing 
both ED and ES strain and stress values even more than what was calculated in this 
study. Other computational studies have, however, circumvented the use of a 
circulation model by adapting pressure and volume changes within the LV to model the 
behaviour of passive inflation and active contraction. Many models utilise an internal 
pressure increase to simulation filling (Vetter and McCulloch, 2000b, Walker et al., 
2008). Systole has also been simulated without the use of a circulation model by simply 
applying an active contraction until the desired ES volume is reached (Walker et al., 
2008). Therefore, although a Windkessel or similar circulation model would be ideal to 
account for pre- and after-load effects, it is not necessary to achieve accurate and 
meaningful results.  
The model also does not incorporate electromechanical coupling. A weakly coupled 
electromechanical model would simulate electrical activation using the Eikonal model, 
for example, and then use the time map from the activation model to coordinate 
mechanical contraction at specific activation times for individual nodes in the mesh. In 
a strongly coupled model, the electrical and mechanical equations would be solved 
simultaneously (Nickerson et al., 2005). Despite the apparent usefulness and precision 
that electromechanical coupling would bring, electromechanics would greatly increase 
computation time. Many groups have modelled the mechanics of the LV assuming 
simultaneous contraction of all regions of the LV (Walker et al., 2005, Guccione et al., 
1995, Hunter et al., 1992). The results of this simplification have been verified with in 
vivo data and it is apparent that electromechanical coupling isn’t necessary when only 
assessing the mechanics of the LV. To analyse electrical activation, needed for assessing 
resynchronisation therapies, electromechanical coupling would become necessary.  
The hydrogel was modelled using the same constitutive law as was used for the 
myocardium with values for constitutive parameters of the hydrogel based on 
unpublished data. Ideally, a constitutive law should be developed to accurately model 
the mechanical behaviour of the polyethylene glycol (PEG) hydrogel. Similar studies, 
however, modelled the injection only as an increase in volume and did not model the 
Un
ive
rsi
ty 
of 
 C
ap
e T
ow
n
76 
 
gel as a separate material within the myocardium (Wall et al., 2006, Wenk et al., 
2011b). Wenk et al. (2011) optimised the parameters of the myocardium with injected 
medium to produce an akinetic material. Therefore, the constitutive model is based on 
no experimentally measured material parameters. Recently, micro-indentation testing 
was performed at Eindhoven University of Technology on the PEG hydrogel used in our 
in vivo studies to provide experimental data with which to fit a constitutive law. Future 
work will incorporate the PEG hydrogel specific constitutive model. 
Based on the current study, it is suggested to expand the investigations to study the 
amount of biomaterial that is injected, location of injection (infarct or BZ) and material 
properties of the injectate. By altering the thickened geometry at each, acute and 
fibrotic phase, the simulated amount of biomaterial injection can be increased or 
decreased. Similarly, the location of wall thickening can be changed to simulate 
hydrogel injections in areas other than the infarct. To explore the effect of hydrogel 
stiffness, the same models could be used but with different material properties for the 
PEG gel. One benefit previously discussed of synthetic biomaterials is that their 
material properties can be adapted relatively easily. Therefore, FE modelling could be 
used to find the optimal material parameters of the hydrogel. Through these 
expansions of the current FE model, the fibre stresses and strains as well as the cardiac 
functional parameters can be compared to determine the optimal design parameters of 
post-MI hydrogel injection therapy. The results can then guide future studies using 
animal models.  
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6. Conclusions 
Finite element analysis was successfully accomplished using the freely available  
software Continuity 6.3b and the results were validated using strain and stress values 
from literature. Post-infarct hydrogel injection therapy was evaluated on the efficacy of 
a) improving cardiac functional parameters, b) reducing elevated myofibre stress in 
the infarct and BZ regions and c) reducing elevated myofibre strain in the infarct and 
BZ regions. After a MI, elevated myofibre stresses in the BZ and remote regions of the 
myocardium lead to volume-overload hypertrophy and remodelling of healthy tissue. 
One goal of any post-MI therapy is to reduce elevated myofibre stresses. In addition, 
the efficiency of the heart as a pump decreases significantly due to infarct wall thinning 
and LV dilation as a result of increased strains in the infarct region. Even small 
reductions in ventricular wall thickness indicate a poor prognosis and eventual HF. 
Therefore, infarct fibre strains should also be alleviated to prevent dilation and wall 
thinning. Fibre stress and fibre strain, therefore, were evaluated to determine the 
mechanical effects of simulated injected PEG hydrogel on the LV.  
The inclusion of hydrogel layers caused a reduction in EDV in both the acute and 
fibrotic infarct models. Although LV dilation at ED was reduced in the acute infarct 
model, the addition of hydrogel caused a significantly lower EDV, below that recorded 
in the healthy model. Therefore, there was neither an advantage nor disadvantage on 
EDV due to hydrogel injection. There was no improvement in contractility of the LV 
due to the layered and bulk injected hydrogel. Ejection fraction (EF) was reduced by 
the introduction of both the acute and fibrotic infarcts into the LV model. The addition 
of hydrogel caused a slight increase in EF in the acute model which is most likely 
attributed to the increase in wall thickness and subsequent decrease in LV cavity 
volume. There was no positive effect on EF with the inclusion of hydrogel layers in the 
fibrotic model. Therefore, from analysis of the cardiac functional parameters alone, it is 
not clear that PEG injection has a beneficial effect on cardiac function. 
However, looking at fibre stress and fibre strain in the various regions of the LV at both 
ED and ES time points, a clearer effect can be noticed. Inclusion of hydrogel caused a 
reduction in infarct and BZ myofibre stress in the acute and fibrotic infarct models at 
both ED and ES time points. This reduction in elevated myofibre stress could possibly 
prevent hypertrophy of the BZ and remote tissue. Reduced ES infarct fibre stress, 
resulting from hydrogel injection, can limit the possibility of infarct rupture. As well, 
hydrogel injection reduced ED and ES infarct and BZ fibre strain in the acute and 
fibrotic infarct models, which could signify a reduction in stretching of the myocardium 
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which leads to wall thinning and dilation of the LV. ES fibre strain was greatly reduced 
in the BZ region and mean ES LV fibre strain also improved. Hydrogel injection 
therefore, has the ability to reduce LV wall thinning and dilation as well as elevated 
myofibre stresses. In general, the developed models helped explore the mechanics 
behind biomaterial injection therapy. The results of this research provide a framework 
for future computational studies addressing some of the limitations addressed 
previously.  
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